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Abbreviations 
 
For some of the proteins, the origin of the abbreviation could not be deduced. In 
these cases, or if the full designation held little information on the function of the 
protein, some additional information is given.  
 
cCBL casitas B-lineage lymphoma proto-oncogene, E3 ubiquitin-protein 
ligase 
CD28 T-cell-specific surface glycoprotein CD28 
CD3ε T-cell surface glycoprotein CD3ε-chain 
CD3ζ T-cell surface glycoprotein CD3ζ-chain 
CFP cyan fluorescent protein 
CSK cSRK kinase 
FCCS fluorescence cross-correlation spectroscopy  
FCS fluorescence correlation spectroscopy 
FYB FYN-binding protein;  
synonym: SLAP, SLP76 associated phosphoprotein 
FYN proto-oncogene tyrosine-protein kinase 
GAB2 GRB2-associated binding protein 2 
GADS GRB2-related adapter protein downstream of SHC 
GEM glycosphingolipid-enriched membrane microdomain 
GFP green fluorescent protein 
GRB2 growth factor receptor bound protein 
ITAM  immunoreceptor tyrosine-based activation motif 
ITK synonym: TSK, T-cell-specific kinase 
LAT linker for activation of T-cells 
LCK lymphocyte cell-specific protein-tyrosine kinase 
MHC major histocompatibility complex 
NCK SH2/SH3 adapter protein 
PAG phosphoprotein associated with GEMs 
PAK1 p21-activated kinase1, serine/threonine-protein kinase 
PI3K p85 phosphatidyl inositol 3-kinase, regulatory subunit of 85 kDa 
PLCγ1 phospolipase C gamma 1,  
1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 1 
PSF point spread function 
PTB phosphotyrosine-binding domain 
polyP proline-rich sequence motif 
PV pervanadate  
pY phosphotyrosyl residue 
IV 
SH2 SRC-homology domain 2 
SH3 SRC-homology domain 3 
SHPTP2 SH domain containing protein tyrosine phosphatase 2 
SLP76 SH2 domain containing leukocyte phosphoprotein of 76 kDa 
SOS son-of-sevenless, guanine-nucleotide excange factor for Ras in T-cells 
VAV guanine-nucleotide excange factor for Rho and adapter protein, 
named after the sixth letter of the Hebrew alphabet  
WASP Wiscott Aldrich syndrome protein 
WH WASP-homology domain 
WIP WASP-interacting protein 
YFP yellow fluorescent protein 
ZAP70 zeta-associated protein-tyrosine kinase of 70 kDa 
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1 Introduction 
Cells are crowded with biomolecules (1) and physical interactions of these 
molecules constitute the basis of all life processes. Through genome sequencing and 
proteome analysis, comprehensive lists of all the molecular players involved in 
cellular processes are within reach, and one next pending task is to understand 
their functions and unravel their physical and functional interactions. It has been 
estimated from known structural and interaction data, that the total number of 
protein fold types is about 1000 (2) and the number of interaction types occurring 
between those folds in protein-protein-interaction networks is about 10000 (3). The 
emerging field of proteome-wide analysis of interactions focuses on the question 
which protein-protein interactions are possible in principle (4), and on the gene-
ration of extensive interaction maps by techniques such as two-hybrid screens (5,6).  
On a smaller, yet more immediately function-related scale, a question is, 
which interactions actually take place in the context of a specific cellular process. 
Systems biology investigates the behaviour and relationships of all of the elements 
in a particular biological system. The aim is to build a descriptive, and ultimatily 
predictive, computational model of the system that can be used to gain an in-depth 
understanding of perturbations (e.g. through protein malfunction, or pharmaco-
logical inhibitors) in the system. 
Cellular signal transduction proceeds through cascades of enzymatic reactions 
and the formation and dissipation of molecular complexes. While the enzymatic 
reactions involved have been a subject of intense biochemical research for decades, 
our understanding of the composition and function of protein complexes is still less 
complete (7). Traditionally, protein-protein interactions are investigated on a one-by-
one basis through co-purification approaches like co-immunoprecipitation, yielding 
detailed information on the occurrence of single interactions. One of their assets is, 
that, given good affinity reagents for co-purification, these methods collect 
information from an unmodified system – introduction of exogenous proteins with 
detection tags (e.g. tandem affinity purification tags (8)) is not necessary. However, 
they are blind for the surrounding interaction network in which the interaction 
under scrutiny is embedded. From a systems biological point of view, the reliance 
on endogenous proteins is desirable, but the size of data sets typically generated in 
classical co-purification is too small. Methods for the parallel analysis of molecular 
complexes are therefore a key to further our understanding of cellular signalling.  
The aim of my thesis was to develop methods for the parallel analysis of com-
plexes of endogenous proteins, and to employ them in the context of T-cell signal 
transduction.  
Background 
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2 Background 
2.1 Signal transduction in T-lymphocytes 
A common feature in the organisation and regulation of intracellular processes is the 
use of protein interaction domains. These functional modules direct the association of 
proteins with one another, and with non-proteinaceous cellular elements, such as 
phospholipids or nucleic acids. Notably, many of the domains mediate interactions with 
short, linear peptide motifs (9), which tend to reside in natively disordered protein regions 
(10). For some of the domain classes, systematic screens have delineated preferred binding 
motifs and binding partners present in the cell, for example for SH3 domains(11), WW 
domains(12) and PDZ domains (13). It is likely, that analysis of data sets from large-scale 
interaction screens will uncover more, maybe less widespread, short linear interaction 
motifs(14). Domain-mediated interaction networks likely evolved through partial 
duplication and subsequent specialisation of modules, giving rise to structurally similar, 
but functionally different proteins and protein complexes (15).  
The signal transduction cascade leading to T-cell activation is to a large extent 
triggered by protein-tyrosine kinases (PTKs). The molecular adapters recognising tyrosine 
phosphorylations (pY) are SRC-homology 2 domains (SH2) and phosphotyrosine-binding 
domains (PTB). Additionally to the inducible pY-dependent interactions, associations 
between SRC-homology 3 domains (SH3) and proline-rich (polyP) motifs stabilise 
complexes of signalling proteins. Both types of domains figure prominently in many 
proteins of the upstream signal transduction network in T-cells (16). Figure 1 provides an 
overview the domain structure of some of the principal players involved. 
2.1.1 SH2 and SH3 domains 
SRC-homology domains were first described as sequences homologous to regions in 
the non-catalytic part of the cytoplasmic protein tyrosine kinase SRC (17,18).  
SH2 domains comprise about 100 aminoacyl residues, folded into a conserved 3D 
structure consisting of two α-helices and six or seven β-strands in a continuous β-
meander, forming the core of the domain (19). SH2 domains bind to phosphotyrosyl 
residues in certain sequence contexts, thereby introducing switchable interactions in 
protein-kinase signalling networks. 325 human SH2 domains are catalogued in the 
InterPro database (www.ebi.ac.uk/interpro). Depending on their preferred consensus 
binding motif, usually determined by only few residues C-terminal with respect to the pY 
(positions +1, +2 and +3) SH2 domains are grouped into various classes (Table 1).  
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Table 1: Various classes of SH2 and SH3 domain interacting motifs (according to www.elm.eu.org 
(20)). The IUPAC one letter code for amino acids is used. “.” allows any aminoacyl residue in the 
position, [XYZ] bracketed allows any of the listed aminoacyl residues in the position. 
motif type consensus motif occurs for 
example in  
GRB2-like SH2 pY . [EN] LAT (pY191) 
SHPTP2-, PLCγ1-like SH2 pY [IV] . [VILP] LAT (pY132) 
SRC-like SH2 pY E E I FYN, SRC 
tandem SH2, ITAM [DE] . . pY. . [LI] . 6-12 pY . . [LI] CD3ζ, CD3ε 
Class I SH3 [RKY] . . P . . P PI3Kp85α,  
Class II SH3 P . . P . [KR] PI3Kp85α, SOS1 
Non-canonical Class I SH3 . . . [PV] . . P  
Non-canonical Class II SH3 K P . . [QK] . . .  SRC 
 
 
Phosphopeptides of optimal sequence bind to SH2 domains with dissociation 
constants of ~50-500 nM. The interaction between SH2 domains and their substrates is 
additionally cooperatively stabilised by contacts with other surface regions of the protein 
surface. Some proteins contain two adjoining SH2 domains (a “tandem”-SH2 domain; e.g. 
present in ZAP70, SYK, PI3K-p85α, and SHPTP2; Figure 1), and bind to motifs containing 
two pY residues. While single SH2 domains usually display a preference of 20- to 50-fold 
for their biologically relevant ligand motifs over alternative motifs, tandem-SH2 domains 
benefit of an avidity effect and have 1000-10000 fold increased affinity towards their 
natural ligands (21) compared to single SH2 domains. 
SH3 domains are small modules of about 50 – 60 aminoacyl residues in length. Their 
characteristic domain fold consists of five to six β-strands, forming two anti-parallel β-
sheets. The linker regions in between the β-strands may contain short helical regions. 635 
human SH3 domains are catalogued in the InterPro database. SH3 domains bind to polyP 
sequence motifs that form a left-handed polyproline type II helix. Both ligand orientations 
with respect to the SH3 domain are possible, depending on the position of the positive 
residue in the polyP motif (22) (canonical class I and II SH3 motifs, Table 1). Additionally, 
non-canonical SH3-binding motifs exist. A non-P residue, often R, can form part of the 
binding core by contacting the SH3 domain. Dissociation constants are usually in the 
micromolar range. The binding affinity and specificity can be increased by interactions 
involving loops on the SH3 domain. Additionally, methylation of arginine residues 
adjacent to polyP motifs has been described as a regulatory mechanism for SH3 domain 
binding (23). 
Background 
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2.1.2 Upstream events and molecular players in T-cell signalling 
T-cells can be activated by binding of T-cell receptor (TCR)/CD3-complexes to 
agonistic MHC-peptide complexes on antigen-presenting cells (APC). In addition to the 
contact between TCR/CD3 and MHC/peptide, accessory membrane molecules on T-cells 
and APCs interact, stabilise the cell-cell contact and provide additional stimuli for cellular 
signalling. Prominent among these is the co-stimulus provided by the T-cell surface 
glycoprotein CD28 and its ligands on APCs, CD80 and CD86 (also known as B7.1 and 
B7.2). The events initiated by interaction of TCR/CD3 and CD28 with their APC ligands 
involve overlapping sets of signalling molecules (24). 
The TCR/CD3 complex comprises the clonotypic TCR α and β chains which contact 
the MHC/peptide complex and the invariant CD3 γ, ε, δ and ζ chains . The highly diverse 
sequence and binding specificity of the α and β chains arise through combinatorial genetic 
rearrangement, with some junctional flexibility and possible addition of nucleotides to the 
rearranged sequence. The CD3 chains, typically occurring in dimers of γε, εδ and ζζ, 
contain tyrosine-phosphorylation sites in their intracellular portion. The critical tyrosines 
are found in consensus motifs of 20 – 25 aminoacyl residues, so called immunoreceptor 
tyrosine-based activatory motifs (ITAMs, Table 1, p.3 ). 
The CD3-ITAMs are the starting point of a cascade of tyrosine-phoshorylations, 
induced protein interactions and further activation of kinases and other enzymes 
generating second messengers. In resting cells, protein tyrosine phosphatases (PTPases) 
have a capacity several orders of magnitude higher than that of protein tyrosine kinases 
(PTKs), holding activation through phosphorylation at bay (25). TCR-engagement by MHC-
peptide complex shifts the equilibrium between PTK and PTPase activities through several 
mechanisms.  
The TCR-CD3 complex is accompanied by either CD4 or CD8 co-receptors 
recognising membrane-proximal regions of the class II or class I MHC molecules, 
respectively. The cytoplasmic portion of CD4 or CD8 interacts with the SRC-family kinase 
LCK (lymphocyte cell-specific protein-tyrosine kinase) (26) via short motifs containing two 
cysteines (27). LCK is acylated and partitions to glycosphingolipid-enriched membrane 
microdomains (GEMs). Upon TCR engament, LCK is brought into proximity of CD3 
subunits and phosphorylates their ITAMs (28). LCK itself is subject to regulatory 
phosphorylation events. CD45 is a transmembrane PTPase with an overall deactivating 
effect on LCK through dephosphorylation of pY394 (although CD45 also 
dephosphorylates the inhibitory pY505) (29). The extracellular domain of CD45 is bulky 
enough to exclude the enzyme from regions of tight T-cell APC contact, thus relieving 
LCK-inhibition through spatial segregation (30). In resting cells, LCK-activity is additionally 
downregulated by phosphorylation of Y505 through CSK (31). CSK binds the lipid-raft 
residing, constitutively tyrosine-phosphorylated transmembrane adapter PAG 
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(phosphoprotein associated with GEM) (32). Upon TCR-engagement, PAG is 
dephosphorylated, CSK dissociates from PAG and ceases to inhibit LCK.  
One further substrate of LCK is the SYK-family PTK ZAP70 (ζ-associated protein of 
70 kDa). ZAP70 contains two SH2 domains in tandem and is named for its capacity to 
bind to ITAMs of the CD3 complex phosphorylated by LCK. Most notably CD3ζ  ITAM 1 
(33), but also CD3ε (34) are bound by ZAP70. In vitro affinities for binding of ZAP-70 to 
bisphosphorylated CD3-ITAM peptides are in the lower nanomolar range (21). After 
recruitment to phospho-CD3, ZAP70 is activated through phosphorylation of Y492 and 
Y493 in the kinase activation loop by LCK (35) and autophosphorylation (36). Phosphorylated 
Y319 of ZAP70 interacts with the SH2 domain of LCK, contributing to LCK-dependent 
activation of ZAP70 (37). In contrast, phosphorylation of ZAP70 on Y292 has a negative 
regulatory effect by forming a site for recruitment of the E3-ubiquitin ligase CBL (casitas 
B-lineage lymphoma proto-oncogene) via its PTB domain (38,39). The PTB domain is 
composed of different subdomains comprising a calcium-binding EF hand and a divergent 
SH2 domain (40). In this case, ZAP70 acts as an adapter between CD3ζ and the negative 
regulator CBL, promoting the ubiquitinylation of CD3ζ (41) and termination of TCR-
signalling. 
ZAP70 itself is a PTK and phosphorylates several adapter molecules playing critical 
roles in T-cell signalling, among them the transmembrane protein LAT (linker for 
activation of T-cells) (42) and the cytoplasmic adapter protein SLP76 (SH2 domain 
containing leukocyte phosphoprotein of 76) (43). 
LAT is a palmitoylated transmembrane protein, localised preferentially in GEMs (44), 
and therefore in proximity to the TCR/CD3 complex. Upon TCR engagement, LAT is 
phosphorylated by ZAP70 on several Y residues, among them Y132, 191 and 226, within 
less than a minute (45). The resulting pY motifs represent different classes of SH2-binding 
motifs (Table 1, p. 3) and recruit various SH2 domain containing proteins. Prominent 
among them are the phospholipase Cγ1 (PLCγ1) associating with LATpY132 and the 
adapter proteins GADS or GRB associating with LATpY191 (46,47).  
GADS (Grb2-related adapter downstream of Shc) is an SH3-SH2-SH3 adapter 
protein. The c-terminal SH3 domain of GADS associates constitutively with a polyP motif 
in SLP76 (48). Phosphorylation-dependent recruitment of GADS to LAT therefore gives rise 
to a tetrameric complex of PLCγ1, LAT, GADS and SLP, which is additionally stabilised by 
interaction between the SH3 domain of PLCγ1 with a further polyP motif in SLP76 (49). 
Together, these proteins form the core of the so-called “LAT-signalosome” which acts as a 
scaffold for the association of further proteins, such as VAV and ITK (50,51). 
The SH3-SH2-SH3 adapter protein GRB2 (growth factor receptor bound protein) 
interacts via both of its SH3 domains with the Ras guanine nucleotide excange factor SOS 
(52). GRB2 additionally associates via its SH2 domain with another adapter, SHC, which in 
turn binds to phosphorylated ITAMs of CD3, thus leading to Ras-activation (53).  
Background 
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Figure 1: The domain structure of some proteins involved in T-cell signal transduction. Domain 
schemes are adapted from ProSite (54), based on the information provided in the Swiss-Prot 
database (55). SH2 and SH3 domains figure prominently. The ruler is scaled in amino-acyl 
residues.  
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Association of PLCγ1 with LAT increases the concentration of PLCγ1 in the vicinity of 
its substrate, the membrane lipid phosphatidylinositol-4, 5-bisphosphate (PIP2). PLCγ1 is 
activated by phosphorylation of Y783, presumably through ITK, a PTK of the TEC family 
(45). Moreover, PLCγ1 contains a calcium-binding EF-hand domain, involving calcium in 
the regulation of the activity of PLCγ1. Active PLCγ1 hydrolyses PIP2, generating the 
second messenger molecules inositol-1,4,5-trisphosphate (IP3) and diacylglycerol (DAG).  
IP3 increases the cytoplasmic Ca2+ concentration by acting on ion channels in the ER 
and the plasma membrane. The increased Ca2+-level activates, among other proteins, 
protein kinase C θ (PKCθ).  PKC θ is additionally recruited to the plasma membrane by 
interaction of its Zinc-finger domains with DAG, and is both bound and phosphorylated 
by LCK (56). RasGRP, another Ras guanine nucleotide excange factor, also interacts with 
DAG in the membrane, and is presumably phosphorylated by PKCθ (57). In mature T-cells, 
PKCθ is essential for the NFkB-dependent induction of IL2-expression upon TCR-
crosslinking (58).  
SLP76 is a cytoplasmic adapter protein, containing regulatory tyrosine phospho-
rylation sites, a polyP region (harbouring the interaction sites for the SH3 domains of 
GADS and PLCγ1) and a C-terminal SH2 domain. SLP76 is tyrosine-phosphorylated by 
ZAP70. Phopho-SLP76 interacts with NCK, an adapter protein, and VAV, a guanine-
nucleotide exchange factor (GEF) for Rho-GTPases, providing a link between TCR-
stimulation and reorganisaton of the actin cytoskeleton (59). A phosphorylation-dependent 
trimolecular complex of SLP76, VAV and ITK has been described(50,51), which localises ITK 
to the LAT-signalosome. The SH2 domain of SLP76 mediates interaction with the FYN-
binding potein (FYB) (60). FYB is a cytoplasmic adapter protein, named after its capacity to 
bind the SRC-family protein tyrosine kinase FYN, which has been repoted to be a key 
regulator of the microtubule cytoskeleton in T-cells (61). Furthermore, SLP76 
phosphorylated at tyrosines 113 or 128 interacts with the SH2 domain of PI3K p85 (62). 
CD28 is a disulfide-linked homodimeric single-pass transmembrane protein 
expressed on most peripheral T-cells, which acts costimulatory upon engagement by CD80 
or CD86 on APCs. Like the TCR/CD3 complex, CD28 is not a receptor-tyrosine-kinase. 
Tyrosine residues in the cytoplasmic tail of CD28 are phosphorylated upon CD28 
engagement, presumably by LCK (63) associating via its SH3 domain with polyP motif 
surrounding residues around 187-190 (64). Conversely, CD28 has been decribed to sustain 
autophosphorylation and activation of LCK (65). Additionally, PTK of the TEC-family 
relocate to CD28 upon CD28-crosslinking and associate via their SH3 domains with polyP 
motifs of CD28 (66). Phosphorylation of tyrosine 173 of CD28 results in recruitment of SH2-
containing proteins, such as PI3K (67), and the GRB2-SOS complex (68).  
Phosphoinoside-3-kinases (PI3K) of the class IA are heterodimers of a 85kD 
regulatory and a 110kD catalytic subunit. The regulatory subunit contains a tandem SH2 
domain, which recruits the heterodimer to tyrosine-phosphorylated membrane receptors, 
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such as CD28. The catalytic subunit then phosphorylates the membrane lipid 
phosphatidylinositol-(4,5)-bisphosphate (PIP2), generating phosphatidylinositol-(3,4,5)-
trisphosphate (PIP3). PIP3 is bound by pleckstrin-homology (PH) domains of various 
proteins, among them TEC kinases, which have been implicated in the phosphorylation-
dependent activation of PLCγ1 (69).  
GAB2 is an adapter protein predominantly involved in the negative regulation of T-
cell signalling (70), possessing a PH domain likely responsible for its localisation to the 
plasma membrane upon production of PIP3 by PI3K. Upon CD28 crosslinking, GAB2 is 
tyrosine phosphorylated and associates with the SH-domain containing protein tyrosine 
phosphatase 2 (SHPTP2) (71). Via an atypical SH3 binding motif, GAB2 can bind to SH3 
domains of GADS or GRB2 (72) and thus mediate the dephosphorylation and inactivation of 
molecules in the LAT-signalosome by SHPTP2 (70).  
 
2.2 Fluorescence and confocal fluorescence detection 
2.2.1 Fluorescence 
Luminescence is the emission of light by a molecule relaxing from an electronically 
excited state. In photoluminescence, the molecule has reached the excited state by 
absorption of a photon. In fluorescence, photon emission takes place between electronic 
states of the same spin state (e.g. S1 to S0). Such transitions occur with typical lifetimes of 
the excited state of 10-8 s (73). In phosphorescence, photon emission occurs between 
electronic states of the opposite spin state (e.g. T1 to S0). As these transitions are 
disfavoured by quantum mechanical rules, they occur with a low likelihood and the 
lifetime of the excited state in phosphorescence is considerably longer than in fluorescence 
(10-3s up to s) (73). Both processes have in common, that the wavelength of the emitted 
photon is longer than the wavelength of the originally absorbed photon. This is due to 
nonradiative dissipation of some part of the energy of the excited state, usually through 
collisions with neighbouring molecules. Other processes of nonradiative energy transfer 
are intersystem crossing, by which triplet states are reached, and internal conversions, in 
which a vibrational state from an electronically excited state couples with a vibrational 
state of a lower electronic state (74). The red-shift of fluorescence emission relative to the 
excitation is the basis of fluorescence detection. By using appropriate filters, scattered or 
reflected excitation light is blocked before the respective detector is reached, and only light 
emitted by fuorescence is allowed to pass.  
Numerous fluorophores are employed as probes in the molecular and cellular life 
sciences. The increasing use of lasers for fluorescence excitation (as in laser scanning 
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microscopes, microarray scanners and flow cytometres) constitutes a preference for 
fluorophores with excitation near 488 nm (Argon-laser; e.g. fluorescein), 543 nm (Helium-
Neon-laser; e.g. rhodamin, Cy3) and 633 nm (Helium-Neon-laser; e.g. Cy5). Some 
fluorophores (e.g. propidium iodide) intercalate directly with DNA and are used as 
nuclear trackers or viability markers. However, most fluorophores are covalently attached 
to biomolecules of choice by employing a reactive derivative of the fluorophore (e.g. 
fluorescein isothiocyanate, N-hydroxysuccinimide esters).  
Over the last decade, fluorescent proteins have become an indispensable tool for cell 
biological analysis (75). Most fluorescent proteins in use today are derivatives of the green 
fluorescent protein (GFP) of the jellyfish Aequorea Victoria. This original GFP has been 
adapted to laboratory requirements by introducing numerous mutations, conferring 
enhanced and faster folding, increased pH and ion tolerance, and, not least, different 
spectral characteristics (76,77). The spectral range of available fluorescent proteins has been 
further expanded to long wavelengths by proteins of the DsRed-family, derived originally 
from corals of the species Discosoma (78). 
2.2.2 Confocal fluorescence detection 
The beampath of a widefield epifluorescence microscope is largely analogous to the 
beampath of a classical light microscope. Mercury lamps are usually employed for 
excitation of fluorescence, as their spectrum covers the near UV range as well as the visible 
range of the electromagnetic spectrum. In contrast to transmission illumination in classical 
light microscopy using a condensor, the excitation light in epifluorescence is introduced 
through the objective, which simultaneously collects the fluorescence light emanating 
from the sample. Filter sets comprising an excitation filter, a dichroic mirror and an 
emission filter are used. All fluorophores within the field of vision of the objective 
contribute simultaneously to the fluorescent image of the microscopic specimen, which 
can be viewed through the eyepieces of the microscope. Nowadays, the image is usually 
detected by the light-sensitive chip of a CCD camera.  
This optical setup conserves one of the disadvantages of classical light microscopy: In 
addition to light from the focal plane, out-of-focus information reaches the detector. This 
disadvantage is circumvented by confocal optics (Figure 2). The decisive difference in the 
beampath of a confocal microscope is a pinhole placed in a plane confocal to the object 
plane. The pinhole aperture allows only light from the optically conjugated point on the 
object plane to pass through and reach the detector. A laser focussed through the objective 
to a diffraction limited point is used for excitation. Fluorescence originating from 
fluorophores in the illuminated cones of the focussed laser, but outside of the focal plane, 
is to a large extent blocked by the pinhole. However, confocal detection comes at the price 
of analysing only the fluorescence within the confocal volume element; i.e. one pixel at a 
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time, instead of a whole image. Therefore, confocal images are generated by scanning the 
focal plane in a pixel by pixel fashion. In confocal laser scanning microscopes, this is 
accomplished by a set of mirrors deflecting the laser beam in x and y direction. In confocal 
microarray scanners, different modi of x-y-scanning are used, either the optics move in 
one dimension, while the slide is moved in the other, or the slide is moved in both 
dimensions relative to the fixed optics. 
The diameter of the pinhole aperture determines the degree of confocality of the 
acquired images. In the ideal case, the pinhole is limited to a point, and detection is limited 
to one point in the confocal plane. The image of an ideal point is described by the point 
spread function (PSF), which relates the point to the intensity distribution in the image 
space. The total PSF of ideal confocal laser optics is a convolution of the illumination PSF 
and the detection PSF. In reality, the pinhole is opened to the diameter of the first 
maximum of the PSF in the xy-plane (Airy disk)(79). 
 
 
 
Figure 2: Principle of confocal fluorescence detection (modified from (79))  
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2.3 Fluorescence correlation and cross correlation spectroscopy 
2.3.1 Basics of fluorescence auto- and cross-correlation spectroscopy 
Autocorrelation is the comparison of a series of values with itself, usually in the time- 
or space-domain. In Fluorescence Correlation Spectroscopy (FCS), the temporal 
fluorescence fluctuations detected from fluorophores moving through a laser illuminated 
confocal detection volume (80) are analyzed for their self-similarity after the lag time τ. 
Analysis of the autocorrelation curve then uncovers time constants of processes 
underlying the fluorescence fluctuation and average numbers of molecules in the 
detection volume. In order to enable correlation analysis of the fluorescence fluctuations, 
concentrations of labelled probe molecules should ideally be in the range of 10 nM. At too 
high concentrations (> 500 nM), fluctuation amplitudes are too low to be discriminated 
from noise. FCS requires only microliter amounts of sample. Automated, serial 
measurements of samples in multiwell plates are easily accomplished. Per well, 
fluorescence fluctuations are sampled for seconds up to minutes. An overview of FCS is 
given by Figure 3.  
 
The autocorrelation function G(τ) of the fluorescence fluctuation F(t) is: 
 
2)t(F
)t(F)t(F
1)(G
τ+δ⋅δ+=τ
 
Eq. 1 
 
δF(t) is the difference of the fluctuation and its temporal mean: 
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With the mean fluorescence intensity over the measurement time tm:  
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Eq. 3 
 
In order to interpret the autocorrelation function G(τ) calculated from the fluorescence 
fluctuation signal, a mathematical model of δF(t) is used. This model comprises both the 
optical characteristics of the confocal illumination and detection system and the molecular 
basis of the fluorescence fluctuation:  
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Figure 3: Schematic overview of the principle of fluorescence correlation spectroscopy (FCS) 
measurement (from (81)) 
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In Eq. 4, κ is the overall detection efficiency of the instrument, Iex(r) is the spatial 
distribution of the excitation light with I0 as maximum, S(r) is the collection intensity 
function describing the spatial detection efficiency of the pinhole-objective combination 
used, and δ(σ q c(r,t) describes the dynamics of the fluorophore on the single-particle level 
in terms of fluctuations in the molecular absorption cross-section σ, the quantum yield q, 
and the local particle concentration c(r,t) (82).  
The confocal detection volume Vdet is not sharply limited, but rather its profile 
corresponds to the convolution (Iex(r)/I0) * S(r). In an approximation, the confocal Vdet can 
be described by Gaussian distributions both in the axial and lateral dimension(80): 
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For practical reasons, the 3-dimensional exponential decay given by Eq. 5 is replaced 
by an effective detection volume Veff enclosed by the isocontours of e-2-fold detection 
efficiency relative to the centre of the distribution(83): 
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Eq. 6 
 
S denotes the instrument-specific structure parameter: 
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Eq. 7 
 
where ωz and ωxy are the radii of the detection volume along the optical axis and in the 
optical plane, defined by the isocontour of e-2 detection efficiency relative to the center of 
the confocal detection volume. 
Fluctuations in the local concentration of excitable fluorophore C(r,t) (Eq. 4) may be 
due to various processes, from 3-dimensional Brownian diffusion in solutions to directed 
transport phenomena in cells. Additionally, transitions into ‘dark states’ of the 
fluorophores, e.g. by intersystem crossings or protonation have to be taken into account. 
In all systems analyzed in this thesis, unobstructed translational diffusion was assumed, 
according to Fick’s second law:  
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Eq. 8 
 
D is the diffusion coefficient, usually expressed in the unit cm2 s-1. 
 
Implementing diffusion and transient dark states, the normalised fluorescence 
autocorrelation function reads: 
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τD is the mean dwelling time of a molecule crossing the confocal observation volume by 
lateral diffusion. T and R are the fractions of molecules in a dark state due to triplet 
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transition or a first-order reaction (e.g. protonation, as occurs for YFP(84)). Correspondingly, 
τT and τR are the decay times of such dark states.  
The relationship between D and τD is (85): 
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Eq. 10 
 
The term Veff · ‹C› in Eq. 9 corresponds to the mean particle number N in the detection 
volume. Thus, the autocorrelation amplitude G0(τ=0) is inversely related to the 
concentration of diffusing fluorophores in the sample (Figure 3). If a calibration substance 
with a known diffusion coefficient Dcal is used, the size of Veff and hence the concentration 
of fluorophore-labelled particles can be calculated from Eq. 6, Eq. 10 and the measured 
lateral diffusion time τDcal of the calibrant: 
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Eq. 11 
 
Examples for diffusion coefficients of fluorophores often used for calibration are 2.8 *10-6 
cm2 s-1 for rhodamine-6-g, 3.16 *10-6 cm2 s-1 for Cy-5 (86). The elegance of this approach is, 
that no external concentration standard, established by another method, is needed to 
determine concentrations by FCS. Of course, it is also possible to determine the particle 
number N for a calibrant of known concentration, and calculate concentrations of 
fluorescent analytes accordingly form their particle numbers. 
The relation of the diffusion coefficient D to the hydrodynamic radius of the diffusing 
particles is described by the Stokes-Einstein equation:  
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Eq. 12 
 
k is the Boltzmann constant, T is the temperature, η is the viscosity of the medium. 
Approximate molecular weights M are calculated according to: 
  
3
hA3
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ρ is the mean density of the diffusing particles (for globular proteins, ρ ≈ 1.2 g cm-3 (87) NA is 
Avogadro’s constant.  
Fluorecence cross correlation spectroscopy (FCCS) is an extension of the concept of 
FCS (Figure 4). Typically, two superpositioned lasers are used for excitation. The 
fluorescence fluctuations F1(t) and F2(t) caused by the diffusion of the two spectrally 
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distinct fluorophores 1 and 2 through the detection volume are detected separately by two 
detectors with (sub)microsecond resolution. Suitable pairs of fluorophores employed in 
FCCS are distinguished by minimal overlap between the emission-spectrum of the shorter 
wavelength fluorophore and the excitation spectrum of the longer-wavelength 
fluorophore. This is in contrast to detection of interactions based on fluorescence 
resonance energy transfer (FRET), where spatial proximity of fluorophores with 
overlapping emission-and excitation spectra is the basis of detection(88) .  
Concerted diffusion of different fluorophores due to physical linkage results in 
simultaneous contributions to both fluorescence fluctuations(83). Information on the 
presence of such concerted fluctuations is extracted from the fluorescence signals by 
temporal cross-correlation analysis according to: 
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Eq. 14 
 
In the ideal case of equal size and complete overlap of the detection volumes, and 
complete spectral separation of the signals of both fluorophores by adequate filter sets, the 
cross-correlation function G12(τ) reads (83): 
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C1 and C2 designate concentrations of the singly labelled and C12 of the doubly 
labelled species, respectively. The temporal decay of G12(τ) is governed only by the 
diffusion properties of the doubly labelled species. In the real case, some crosstalk of the 
shorter-wavelength fluorophore into the detection channel for the longer-wavelength 
fluorophore can not be avoided. At τ=0, the amplitude of the cross-correlation function is:  
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Eq. 16 
 
Parameters with index “total” designate the sum of both singly and doubly labelled 
species for fluorophore 1 or 2, respectively. N1total and N2total are derived from the 
autocorrelation functions acquired for both separate channels. In contrast to 
autocorrelation, the amplitude of the cross-correlation function is directly proportional to 
the fraction of doubly labelled particles (Figure 4 C).  
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Figure 4: Schematic of Fluorescence Cross Correlation Spectroscopy: A) Molecules labelled with 
two different fluorophores diffuse through a confocal detection volume. B) The resulting 
fluctuations of the fluorescence of both fluorophores are detected with (sub)microsecond resolution 
and are cross-correlated. C) The fraction of particles carrying both fluorophores is proportional to 
the height of the amplitude of the cross-correlation function Gcc(τ). 
 
 
In the ideal case of complete overlap of equally-sized detection volumes and 100% of 
doubly labelled particles in the sample, the cross-correlation curve and both auto-
correlation curves are identical.  
Both FCS and FCCS are techniques predestined for the detection of molecular 
interactions. In FCS, interactions of a fluorophore-labelled molecule are detected based on 
the changes of its autocorrelation diffusion time τD due to mass gain upon binding. As 
diffusion coefficients are proportional to the cubic root of the molecular weight (Eq. 12 and 
Eq. 13), a detectable increase of the autocorrelation diffusion time requires substancial 
mass increase. Therefore, FCS is primarily employed to detect interactions of labelled, 
small ligands with much larger receptors. In this case, the binding event creates a labelled 
species, i.e. the ligand-receptor complex, with a much larger molecular weight compared 
to the ligand alone. Accordingly, FCS has for example been successfully employed in high-
throughput screening of drug candidates (89). In contrast, FCCS can be employed to 
monitor interactions of partners of similar molecular weight, making it an ideal technique 
for the detection of (bio-) macromolecular interactions. Applications include detection of 
nucleic acid hybridisation (90) and protein-protein interactions. However, due to the 
proportionality of autocorrelation amplitude and fraction of doubly-labelled particles (Eq. 
16), FCCS is not suited for the detection of rare interactions.  
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2.3.2 Intracellular applications of FCS and FCCS  
As the confocal measurement volume has approximately the size and proportions of 
a coliforme bacterium, FCS and FCCS measurements can be also carried out in live, 
eukaryotic cells. Positioning of the measurement volume in a cell is enabled by integration 
of the optics used for FCS and FCCS into an optical microscope, either equipped with 
epifluorescence detection or a confocal laser scanning microscopy module. Interpretation 
of the diffusional characteristics observed by intracellular FCS is complicated by the 
inhomogenous intracellular environment. Intracellular molecule numbers can be 
determined from the autocorrelation amplitude. 
One basic requirement for analysis by FCS is that the fluorescent molecules cross the 
detection volume in a time considerably shorter than the duration of an FCS measurement. 
In the cytoplasm and nucleus, interactions giving rise to diffusible complexes have been 
monitored by FCS(91) and FCCS(92). By contrast, membrane association of the fluorescent 
molecules under scrutiny can impede FCS and FCCS. Measuring the binding of 
fluorescently labelled small-molecule ligands to membrane-bound receptors (93,94) has been 
demonstrated. While recruitment of a GFP-labelled signalling protein to a receptor was 
obvious from an increased fraction of slowly diffusing components, the variation of 
diffusion constants over a wide range prohibited a more detailed analysis of the molecular 
state (95). Finally, receptor clustering in membranes has been reported to immobilise 
proteins beyond the timescale measurable by FCS (96).  
In addition, the need for fluorescent readouts imposes limitations on the application 
of FCS and FCCS, particularly so for the measurement in living cells. For the pairwise 
identification of binding partners, two specific labels conferring properties that can be 
monitored by FCS or FCCS are required. In most cases, interaction partners monitored by 
FCS-based techniques are directly covalently labelled. Protein interactions can be detected 
by expression of the interaction partners as fusion proteins with spectrally different 
fluorescent proteins (97,98,99). Alternatively, chemically labelled fluorescent molecules have 
been introduced into cells by electroporation (92) or receptor-mediated endocytosis (100). 
In addition to FCS and FCCS, a range of other fluorescence-based techniques has 
been applied to the analysis of protein complexes in living cells. These in vivo approaches 
are all based on recombinant versions of the proteins of interest, which carry tags for 
reporting on the interaction. In a system inspired by two-hybrid methods, these tags 
correspond to complementary fragments of fluorescent proteins, which on interaction of 
their fusion parners recombine into a fluorescent species (101,102). Fluorescence resonance 
energy transfer (FRET) has been more widely used, however, this technique reports rather 
on the proximity of molecules than on molecular interactions (103). For drug discovery, 
systems based on cellular bioluminescence resonance energy transfer (BRET) (104) have 
been proposed for the idenfication of compounds interfering with complex formation. 
Background 
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However, due to the need for recombinant reporter proteins, all these in vivo detection 
systems are restricted to the protein complexes for which they were developed, they 
cannot be easily generalised, and considerable efforts are required for the generation and 
validation of suitable fusion proteins and expression levels.  
 
2.4 Microarrays for the parallelised analysis of proteins 
2.4.1 Basic concepts and different formats of arrays 
Microarrays have revolutionised the detection of biomolecules by introducing the 
highly parallel incubation of sample on a multitude of miniaturised probes. Microarrays 
typically consist of 102 – 105 probes arranged in a regular, spatially addressable pattern on 
a solid two-dimensional support. Barely ten years ago a fledgling technique for nucleic 
acid detection (105,106,107), microarray development now rapidly moves forward to tackle 
questions related to the detection and analyis of proteins and their functions (108,109). An 
overall aim is to better understand the expression and function of large, or eventually 
proteome-wide (110), sets of proteins.  
Some of the methodology and technical equipment can be transferred from nucleic 
acid to protein microarrays. However, compared to nucleic acids, proteins are a 
chemically highly heterogeneous group of individuals, and their functionality often 
depends critically on the integrity of their structure. These properties make the use of 
parallel array techniques for proteins a challenge, as working conditions have to be 
identified that accommodate all used proteins at once.  
Different array formats have been developed. A general distinction can be made 
beween capture arrays and reverse arrays. Capture arrays consist of immobilised binding 
molecules, e.g. antibodies or peptides, that pull down their protein targets from the 
incubation solution containing analyte. Antibody capture arrays can therefore be viewed 
as a miniaturised and parallelised variant of immunoaffinity purification. Reverse arrays, 
by contrast, are arrays of immobilised samples, e.g. patient sera or cell lysates, which are 
incubated with detection reagents (again, typically antibodies).  
For both formats, binding of a macromolecule from the incubation solution to the 
binding partner on the array surface is the crucial step. It has been debated, whether 
microspots of molecules act as mass-sensing (111) or as concentration-sensing (112) devices for 
their binding partners in solution. In the first case, binding of ligand to the microspot 
would be dependent on the volume (and hence the total ligand mass) of the incubation 
solution. In the second case, known as ambient analyte theory, the assumption is that the 
concentration of the ligand in the incubation solution is not changed perceptibly by 
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binding of molecules to the microspot, and hence the incubation volume has no influence. 
In the framework of the ambient analyte theory, it has been shown, that mass-transport of 
the macromolecules in solution to the surface is the rate-limiting step in microspot 
immunoassays, slowing down binding reactions by several orders of magnitude 
compared to well-stirred bulk solutions (113).  
The strategy of immobilisation of probes on the array substrate crucially influences 
their functionality. Chemically reactive surfaces, e.g. epoxysilane reacting with thiol- or 
amino-groups, may result in random orientation, and possibly partially denatured and 
nonfunctional proteins. Directional immobilisation via protein tags (e.g. His-tags on Ni-
NTA-surfaces (110)) results in uniform orientation of the capture molecules on the array 
surface and is presumably better suited to preserve their structure and function. Thin 
polymer gels, so called hydrogels, provide an aqueous environment for deposited proteins 
and, due to their 3-dimensionality, allow deposition of relatively large substance amounts. 
If peptides are used as capture molecules on an array, conservation of structure is less 
critical than for full-length proteins. Peptides can be synthesised in situ as microspots on 
glass slides using photolithographic approaches (114), or as macrospots on membranes 
through SPOT synthesis (115). Alternatively, peptides synthesised by conventional solid 
phase chemistry can be attached to microarray substrates, e.g. through reaction of thiol- 
and amino-moieties with epoxy-activated glass slides. 
Protein arrays are usually generated from overexpressed and purified proteins (110), 
often making availability of large sets of proteins a limiting bottleneck for protein array 
applications. Circumventing this problem, cell-free expression of proteins with tags for 
direct immobilisation on a tag-binding surface (116) has been employed to express and 
immobilise proteins in-situ on cDNA microarrays (117).  
Detection of binding events on arrays is usually based on fluorescence. Either, 
analyte molecules are labelled directly with fluorophores. Amine-reactive dyes reacting 
via their succinimidyl ester moieties with primary amines of proteins are commonly used. 
Strategies analogous to the two-colour-ratio experiments with DNA-arrays exist, where 
proteins in two samples to be compared are directly chemically labelled with different 
fluorophores and then incubated on the same array (118). The ratio of both fluorescence 
signals on each spot of the array corresponds to the relative amounts of the bound protein 
present in the samples, and taken together the the experiment allows to determine overall 
diffential translation profiles. Alternatively, proteins in just one sample are biotinylated, 
and then detected on the array by fluorescently labelled streptavidin (110). The advantage of 
this strategy is that all analytes bound to the array can be detected with just one reagent. 
However, in both detection strategies, signals are determined by just one binding event to 
the capture molecule. Signals due to unspecific binding of analytes to arrayed capture 
molecules or crossreactivity may occurr, and cannot be easily told apart from signals of 
bona fide interaction partners.  
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To circumvent this problem, dual-level recognition of analytes is preferable, making 
erroneous identification of proteins much more unlikely. Analytes in the sample are 
captured by a binder immobilised on the array, and detection is based on a second 
recognition event by another binder. In most cases, the resulting protocol is essentially a 
miniaturised and multiplexed adaptation of a classical antibody sandwich assay. The first 
set of immobilised antibodies captures their target proteins from the analyte mixture. The 
antibodies in a second set (which have to recognise other epitopes) are either labelled with 
biotin, again allowing detection by fluorophore-labelled streptavidin, or are detected by 
fluorophore-labelled secondary antibodies. Although multiplexing is an attractive option 
for the parallel detection of multiple analytes, there is a general consensus that, due to 
low-level cross reactivity even of highly specific antibodies, multiplex sandwich assays are 
limited to the parallel detection of about 50 analytes (119). 
For readout of fluorescence on arrays, both confocal and non-confocal microarray 
scanners are used. Special array formats also allow the coupling of excitation light into a 
planar waveguide, and the excitation of fluorescence by the evanescent field. 
2.4.2 Brief overview of applications 
Microarrays have been applied to a wide range of questions in the analysis of large 
protein sets.  
In analogy to the applications of DNA arrays for transcriptional profiling (120), 
antibody arrays are used for translational profiling (121,122) of biological and clinical samples. 
For example, patient sera and sera of healthy control donors were directly labelled with 
different fluorophores and applied to antibody microarrays, in order to identify potential 
prostate cancer biomarkers based on their differential expression in health and disease (118).  
Sandwich-assays based on antibody microarrays and a second set of detection 
antibodies have been used for the multiplex detection and quantitation of cytokine and 
chemokine levels in biological samples (reviewed in (123)). 
In reverse-capture approaches, protein microarrays comprising auto-antigens for 
tumors or autoimmune disorders are used to screen for the presence of autoreactive 
antibodies (124,125,126).  
A microarray comprising 80% of the proteins of the yeast proteome has been 
presented (110). 5800 open reading frames were cloned, and their encoded proteins were 
overexpressed, purified and printed in microarray format. When the arrays were screened 
for binding of calmodulin and phospholipids, many hitherto unknown binding partners 
were identified, demonstrating the potential of protein microarrays for the analysis binary 
interactions in biomolecular interaction networks. 
In the context of signalling-dependent changes, antibody microarrays were used to 
detect and quantify tyrosine kinase signalling (127). Pan-specific capture antbodies were 
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used together with differentiall labelled phospho-specific and pan-specific detection 
antibodies. 
In summary, microarrays are used to detect the presence of biomolecules, or 
modified biomolecules, of interest and quantify their levels. However, biological function 
is not only determined by the presence or absence of molecular players, but also by their 
interaction state. The formation of protein complexes in cellular signalling is a prominent 
example. Given the complexity of signalling networks, the application of methods for the 
parallel detection of interaction events seems evident. In this respect, microarrays provide 
an intriguing basis, but conceptual advances are required to turn arrays into devices for 
the parallel detection of signalling-dependent protein-protein interactions. 
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3 General Materials and Methods 
3.1 Basic buffers 
Phosphate-buffered saline (PBS) 
1.5 mM KH2PO4, 8.1 mM Na2HPO4,  137 mM NaCl, 2.7 mM KCl (pH 7.4) 
 
PBS-Tween 
PBS, 0.05 % (v/v) Tween-20 
 
HEPES buffered saline (HBS) 
10 mM HEPES, 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM CaCl2 (pH 7.4) 
 
HBS-BSA/Glucose 
HBS, 5 mM Glucose, 0.1% (w/v) BSA 
 
Lysis buffer 
1% Triton X100, 20 mM Tris, 1mM EDTA, 150 mM NaCl, 50 mM n-octyl β-D-
glucopyranoside (Fluka, Taufkirchen, Germany) (pH 7.5). 1mM Na3VO4 and 1x 
Protease Inhibitor Cocktail (Complete Protease Inhibitor Cocktail tablets; Roche, 
Mannheim, Germany) were added directly before use. β-D-glucopyranoside ensures 
the efficient extraction of proteins residing in membrane rafts(128). If this is not a 
concern, the reagent may be omitted. 
 
Antibody dilution buffer for FCCS (AD-buffer) 
PBS, 0.1% (w/v) BSA 
 
SDS page running buffer (5x) 
250 mM TrisHCl, 1.9 M glycin, 0.5% SDS (pH approx. 8.6, no adjustment) 
 
Resolving gel buffer (4x) 
1.5 M Tris-HCl (pH 8.8), 4 mM EDTA 
 
Stacking gel buffer (4x) 
0.5 M Tris-HCl (pH 6.8), 4 mM EDTA 
 
Resolving gel mix, 12.5% acrylamide 
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2.1 ml ddH2O, 1.55 ml 40% acrylamide/N,N´-methylene-bisacrylamide (37.5:1, 
BioRad), 1.25 ml resolving gel buffer (4x), 50 µl 10% (w/v) SDS, 50 µl 10% (w/v) APS, 5 
µl TEMED. 
 
Stacking gel mix, 4% acrylamide 
1.6 ml ddH2O, 0.25 ml 40% acrylamide/N,N´-methylene-bisacrylamide (37.5:1), 0.625 
ml stacking gel buffer (4x), 25 µl 10% (w/v) SDS, 40 µl 10% (w/v) APS, 4 µl TEMED. 
 
SDS-PAGE sample buffer (5x) 
250 mM Tris-HCl (pH 6.8), 500 mM DTT, 0.5% bromephenol blue, 50% (v/v) glycerol, 
10% (w/v) SDS 
 
Blotting buffer 
192 mM glycine, 25 mM Tris-HCl, 20 % (v/v) methanol (pH 8.3) 
 
Alkaline phosphatase buffer (5x) 
500 mM Tris-HCl, 500 mM NaCl, 25 mM MgCl2 (pH 9.5) 
 
Reagent for alkaline posphatase detection 
90 mg/ml nitroblue tetrazolium in 70% DMF, 45 mg/ml 5-Bromo-4-chloro-3-indolyl-
phosphate in ddH2O; storage at -20°C°; use at 20 µl each per 5 ml 1x alkaline 
phosphatase buffer 
 
Array blocking buffer  
PBS with 1% (w/v) Top Block (Fluka) 
 
Array wash buffer: PBS-Tween/BSA 
PBS, 0.05% (w/v) BSA, 0.05% (v/v) Tween-20. Array wash buffer was also used for 
dilution of antibodies for incubation on the arrays. 
3.2 Peptides 
Peptides were supplied by EMC microcollections, Tübingen. All peptides contained 
an N-terminal cysteine residue with free amino-terminus for efficient immobilisation on 
epoxy-activated surfaces. Table 2 lists the peptides that were used in this work. Peptide 
designations are derived from the protein containing the peptide sequence; names for 
phospho-tyrosine (pY) peptides additionally contain the number of the pY residue within 
the protein (according to Swiss-Prot, www.expasy.org), names for other peptides contain 
the number of the first residue in the peptide.  
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Table 2: Peptides used in this thesis. pY designates phosphotyrosyl residues. Peptide designations 
in parenthesis correspond to the name used for the peptide during synthesis and analytics. 
Peptide  Sequence Source 
Interaction Partner and 
binding domain 
CD3zpY72/83 
(KK 37) 
C-AhxNQL(pY)NELNLGRREE(pY)DVL-CONH2 
(129) 
CD3ζ ITAM1 
69-86 
ZAP70 
SH2 
SigpY437  
(KK80) 
CGEEREIQ(pY)APLSFHKG-CONH2 (130) Siglec-7 ITIM 
430-445 
SHP-1/SHP-2 
SH2 
LATpY132 
(KK83) 
CEDEDDYHNPG(pY)LVVLPDSTP-CONH2(46,131) LAT-Y-132 
121-141 
PLCγ1 
SH2 
LATpY191 
(KK87) 
CEASLDGSRE(pY)VNVSQEL-CONH2 (131,47) LAT-Y-191 
181-198 
VAV, GADS, GRB2, PLCγ1 
SH2 
LATpY226 
(KK89) 
CEVEEEGAPD(pY)ENLQELN-CONH2 (47,132) LAT-Y-226 
217-233 
GADS, GRB2, VAV 
SH2 
SLP228  
(WH4) 
CAKLPAPSIDRSTKPPLDRS-CONH2 (133) SLP76 
228-246 
GADS 
c-term. SH3 
WIP446  
(WH6) 
CEDEWESRFYFHPISDLPPP-CONH2 (134) WIP 
446-464 
WASP 
WH1 
PAG421  
(WH10)  
CSDLQQGRDITRL-COOH (135) PAG 
421-432 
EBP-50 
PDZ 
ZAPpY319 
(WH21) 
CVYESP(pY)SDPEELKD-CONH2  (37) ZAP70 Y-319 
314-327 
LCK 
SH2 
ZAPpY296 
(WH25) 
CIDTLNSDG(pY)TPEPARIT-CONH2  (38) ZAP70 Y-296 
284-300 
cCBL 
PTB 
PAK6  
(WH29) 
CLDIQDKPPAPPMRNT-CONH2  (136) hPAK1 
6-20 
NCK 
SH3 
SLP179  
(OS3) 
CSGKTPQQPPVPPQRPMAAL SLP76 179-197 PLC 
SH3 
FYB pY595  
(OS4) 
CEDDQEV(pY)DDVAEQD-NH2 FYB 589-602 FYN, SLP76 
SH2 
FYB pY625  
(OS6) 
CDDDI(pY)DGIEEED-NH2 FYB 621-632 FYN2 
SH 
FYB pY651  
(OS7) 
CLDMGDEV(pY)DDVDTSDF-NH2 FYB 644-659 SLP76 
SH2 
LCK pY505 
(OS8) 
CVLEDFFTATEGQ(pY)QPQP LCK pY505 LCK  
SH2 
SHPTP1pY564 
(KK93) 
CSKHKEDV(pY)ENLHTKNK-NH2 SHPTP1 LCK 
SH2 
GAB2-509 
(KK94) 
CQPPPVNRNLKPDRKAKPTPLD-NH2 GAB2  GRB2 
SH3  
GAB2 pY614 
(KK95) 
CKSTGSVD(pY)LALDFQPS-NH2 GAB2 pY614 SHPTP1 
SH2 
CD28pY191 
(KK96) 
CSRLLHSD(pY)MNMTPRRP-NH2 (137) CD28pY191 GRB2, PI3K 
SH2 
cCBL pY699 
(KK98) 
CEGEEDTE(pY)MTPSSRPL-NH2 (138) cCBL pY699 VAV 
SH2 
PLCg pY 
(83KK108) 
CEGRNPGF(pY)VEANPMPT-NH2 PLCγ1 pY 783 PLCγ1 
SH2 
PI3K84  
(KK109) 
CPTPKPRPPRPLPVAPGSSKT-NH2 PI3K p85α 
84-104 
FYN 
SH3 
CD28 pY202 
(KK114) 
CTRKHYQP(pY)APPRDFAA CD28 pY202 GRB2 
SH2 
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3.3 Antibodies 
Antibodies for detection of proteins both on microarrays and in FCS and FCCS had to 
recognise their target proteins in a non-denatured state. Therefore, antibodies certified for 
immunoprecipitation were chosen if available. For detection by secondary antibodies, 
pairs of primary antibodies used together in one experiment were chosen so that one 
antibody was from mouse and the other one from rabbit. Used primary antibodies are 
listed in Table 3. 
Table 3: Primary antibodies used for FCCS or mass-tag FCS (FCS) or peptide microarrays (MA). 
Target protein Type of ab Application Supplier 
PLCγ1 Rabbit polyclonal FCS, MA Santa Cruz 
LAT Mouse IgG1, clone 11B.12 FCS, MA Upstate 
SLP76 Mouse IgG2a, clone 2B2.98 FCS, MA USBiological 
GADS Rabbit polyclonal FCS, MA Upstate 
SHPTP2 Rabbit polyclonal MA Santa Cruz 
CD28 Mouse IgG1, clone CD28.2  Pharmingen 
cCBL Mouse IgG1, clone 17 MA BectonDickinson 
GRB2 Rabbit polyclonal FCS, MA Santa Cruz 
LCK Mouse IgG2b, clone 3A5 MA Upstate 
NCK Rabbit polyclonal MA US Biologicals 
ZAP70 Mouse IgG2a, clone 29 FCS, MA BectonDickinson 
GAB1 Rabbit polyclonal MA Santa Cruz 
FYB Mouse IgG1, clone 5 MA BectonDickinson 
FYN Mouse IgG1 MA Santa Cruz 
WASP Mouse IgG1 MA Santa Cruz 
VAV Rabbit polyclonal MA Santa Cruz 
pLAT(226) Rabbit polyclonal  MA Upstate 
PI3K Rabbit polyclonal MA Transduction Labs 
pPLCγ1(783) Rabbit polyclonal  MA Cell Signalling 
CD3ε Biotinylated hamster IgG1, 
clone 2C11 
FCS, MA BectonDickinson 
CD3ζ Mouse IgG1, clone 6B10.2 FCS, MA Santa Cruz 
CD3ε hamster IgG1, clone 2C11 FCS, MA BectonDickinson 
phospoY Mouse IgG1; # 9411 MA Cell Signalling 
 
 
Secondary reagents were Cy5-labelled streptavidin (Dianova, Hamburg), Alexa488- 
and Alexa633-labelled goat-anti-mouse and goat-anti-rabbit antibodies (highly cross-
absorbed, Molecular Probes, Leyden, The Netherlands), Alexa647 labelled IgG2a Fab 
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fragments (Zenon system, Molecular Probes), Cy5-labelled goat anti-hamster antibodies 
(Dianova), Cy5-labelled goat anti-mouse antibodies (Dianova) and Protein G or 
streptavidin nanoparticles of 50nm diameter (µMACS MicroBeads, Miltenyi Biotec, 
Bergisch Gladbach, Germany). 
3.4 Cell culture, stimulation and lysis 
Human Jurkat T leukemia cells, Jurkat cells lacking PLCγ1 (J.gamma1(139), ATCC # 
CRL-2678) and Jurkat cells expressing kinase-dead LCK (J.CaM1.6(140), ATCC # CRL-2063, a 
kind gift of Claus Belka, Tübingen) were kept in RPMI supplemented with 10% fetal calf 
serum at 37°C and 5% CO2.  
Mouse 3A9 T-hybridoma cells and derivatives transfected with a fusion protein of 
ZAP70 and the yellow fluorescent protein (YFP), or both free YFP and a fusion protein of 
the CD3ζ-chain with cyan fluorescent protein (CFP) were cultured in DMEM 
supplemented with 10 % fetal calf serum, 100 µM sodium pyruvate, non-essential amino 
acids, and 200 µM L-glutamine. The generation of the transfected cell lines has been 
described elsewhere(141) .  
The broad-range phosphatase inhibitor sodium pervanadate was generated in a 
freshly prepared mixture of equal volumes of 10 mM Na3VO4 and 10 mM H2O2 
(corresponding to 1:1000 (v/v) dilution) in HBS. The solution was incubated at room 
temperature for 15 min and used immediately at a tenfold dilution(142). For activation, cells 
suspended in HBS/BSA/Glucose were incubated with pervanadate for 20 min at 37 °C.  
For TCR-mediated stimulation, 107cells per ml were resuspended in ice-cold 
HBS/BSA/glucose containing 10 µg/ml of the anti-CD3 antibody (OKT-3, G. Jung, Institute 
for Immunology, University of Tübingen) or the isotype control (mouse IgG2a, Sigma) and 
incubated on ice for 10 min. Then, the crosslinking secondary antibody (goat anti-mouse 
IgG, Calbiochem), was added to a final concentration of 20 µg/ml and the samples were 
immediately transferred into a 37°C water bath for timespans between 2 and 30 min. 
Stimulation was stopped by adding an excess of ice-cold HBS and placing the samples on 
ice. To remove remaining unbound antibody, cells were washed with ice-cold HBS. 
Cell lysates were prepared by suspension of cells in lysis buffer. For microarray 
experiments, routinely 2 * 107 cells per 1 ml of lysis buffer were used, corresponding to 106 
cells per 50 µl lysate user for each array. For FCCS and mass-tag FCS, 107 – 5*107 cells per 1 
ml of lysis buffer were used. After lysis on ice for 30 min, the crude lysates were clarified 
by centrifugation at 20,000 x g for 15 min. Total protein concentration of lysates was 
determined by a standard protein assay (BioRad, Munich, Germany).  
For competition experiments, peptides were added upon lysis to the indicated final 
concentrations.  
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3.5 Immunoprecipitation, SDS-page and western blotting 
Samples for immunoprecipitation were prepared as described for mass-tag FCS (see 
4.1.1), scaled up by a factor of 6.5. After centrifugation (14,000 × g, 4°C, 10 min) the pellets 
were washed twice with lysis buffer, and once with PBS, followed by resuspension in 1x 
sample buffer and heating to 95°C for 5 min.  
SDS-PAGE of lysates or immunoprecipitation samples was carried out according to 
the procedure described by Laemmli(143). The gel was blotted on a PVDF membrane 
(Millipore, Schwalbach, Germany). After blocking with 5 % nonfat dry milk powder in 
PBS-Tween, the blot was developed using primary and cognate alkaline phosphatase-
conjugated secondary antibody (Sigma, Munich, Germany) and NBT-BCIP substrate. 
Western bands were quantified by scanning the blots and integrating mean signal 
intensity and area of the bands. 
3.6 FCS of ZAP70-YFP in cell lysates 
A ConfoCor2-module, coupled to an Axiovert 100 M inverted microscope stand, 
equipped with a C-Apochromat 40-fold water-immersion objective, NA 1.2 (Carl Zeiss, 
Jena, Germany) was used. YFP was excited at 514 nm by an argon ion laser and detected 
using an infrared-blocking 535-590 nm bandpass filter. Rhodamine-6-G was used as a 
calibrant for pinhole adjustment and for determination of the structure parameter S. Each 
lysate sample was kept on ice until measurement. 20 µl per sample were measured in a 
384-well glass bottom plate (175 µm glass thickness; M-plates, cat.-no. 60200, MMI, 
Glattbrugg, Switzerland). 
Routinely, 10 measurements of 15 s duration each were taken per sample. 
Autocorrelations of YFP were fitted between 10 µs and 1 s with a formalism accounting for 
one diffusing species and the protonation-dependent blinking of YFP (84).  
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This fit was carried out in the ConfoCor2 software (version 2.8), using the 
implemented fit function for one diffusing species and triplet transitions (comprising an 
exponential term analogous to that in Eq. 17). For YFP, the output triplet time constant 
was reinterpreted as protonation-fluctuation time constant. 
ωxy was determined according to Eq. 10 from the calibration measurement of 
rhodamine-6-G (D = 2.8 10-6 cm2 s-1), enabling further calculation of Veff (Eq. 6). With these 
parameters, the concentration c (Eq. 11), the diffusion coefficient D (Eq. 10), and the 
approximate hydrodynamic radius rh (Eq. 12) and molecular weight M (Eq. 13) of the YFP-
containing species in the samples were calculated.  
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3.7 Cellular FCS measurements 
For cellular FCS-measurements, 8-well chamber slides (NUNC, Wiesbaden, 
Germany) were coated for 1 hour with 100 µl poly-L-lysine solution (0.01%, MW 70-150 
kDa, Sigma). Coated chambers were washed twice with HBS. 3A9 cells expressing ZAP70-
YFP were suspended in HBS/BSA/Glucose at cell densities of 106 per ml. Optionally, pre-
incubated pervanadate solution was added (see 3.4). 200 µl cell suspension were used per 
chamber.  
Instrument settings for the ConfoCor2 were as described for the measurement in 
lysates (see 3.6). Additionally, the epifluorescence unit and CCD camera (SensiCam, PCO, 
Kehlheim, Germany) of the Axiovert 100 M microscope were used for imaging of the cells. 
In order to determine the position of the FCS-laser beam within the field of vision, a slide 
covered with a dried solution of rhodamine-6-G was focused, and subsequently submitted 
to bleaching by the laser. By comparison of the epifluorescent images taken of the surface 
before and after bleaching, the xy-position of the laser focus could be determined with an 
approximate lateral precision of 2 µm. For cellular measurements, cells were moved to the 
xy-position of the laser by the moving the microscope stage. Positioning of the laser focus 
along the optical axis z was performed by scanning the fluorescence count rate profile in z-
direction in the ConfoCor software. Profiles displayed a distinct increase in fluorescence 
count rate upon entering the cell, slightly decreased count rate while traversing the 
nucleus, and again increased count rates before leaving the cell. 15 measurements of 10 s 
each were carried out per cell. The first of this measurements was routinely excluded from 
analysis by curve fitting, due to non-negligible photobleaching of immobile molecules. 
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4 Methods developed during the thesis 
A considerable part of the laboratory work carried out for this thesis was the 
development and optimisation of methods for the detection of interactions of endogenous 
proteins from crude cell lysates. This chapter contains concise descriptions of these 
methods per se, in order to facilitate reproduction of experiments and avoid overfreighting 
of the results capters. 
4.1 Protein complex detection by mass-tag FCS and FCCS 
Parts of this chapter were originally written for a protocol (144) published in addition to the 
original paper describing this method (145). 
4.1.1 Sample preparation 
For the sake of general applicability, this protocol describes the detection of the 
interaction of protein X with protein Y. anti-X and anti-Y are the primary unlabelled 
antibodies, anti-anti-X and anti-anti-Y are the secondary reagents. The following options A 
and B for sample composition list the reagent need for per FCCS sample. For the detection 
of most interactions described in chapters 5.2.2 and 5.2.2.3, option A, employing two 
bivalent secondary antibodies, was used. Option B was used if excessive formation of 
immunocomplexes between one primary and the cognate secondary antibody occurred, as 
was the case for anti-SLP76 and goat-anti-mouse-Alexa488. In that case, the bivalent 
secondary reagent was replaced by Alexa647-labelled Fab fragments (Zenon, Molecular 
Probes/Invitrogen). Option C describes how mass-tag FCS samples probing for ZAP70-
CD3ε/ζ interactions were prepared.  
Antibodies were prediluted in AD-buffer. If multiple samples probing for the same 
interaction and hence using the same set of antibodies were prepared, master mixes were 
created of the pair of primary antibodies and the pair of secondary antibodies. 
Incorporation of matching primary and secondary antibodies into the same ‘master mix’ 
was avoided, as their still relatively high concentration might have promoted the 
formation of large crosslinked complexes (see troubleshooting, Table 4, p. 32). 
 
Option A: 
anti-X (25 µg/ml stock)   1.6 µl 
anti-Y (25 µg/ml stock)   1.6 µl 
clarified cell lysate   20 µl 
anti-anti-X-Alexa488 (25 µg/ml stock)  1.6 µl 
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anti-anti-Y-Alexa633 (25 µg/ml stock)  1.6 µl 
For each antibody combination, a control sample was prepared as above, but cell 
lysate was replaced by lysis buffer. 
The final concentration of each antibody in samples prepared according to option A 
was 10 nM (assuming MW 150 kDa). This is in the ideal concentration range for 
fluorescence cross-correlation analysis. Equimolarity of primary and secondary 
binders minimises the presence of primary binders without indirect label or of free 
fluorophore-labelled secondary binders (confer Table 11, p. 86). Both would decrease 
the fraction of doubly labelled particles, and hence the cross-correlation amplitude. 
The control sample was necessary to assess any interactions of the binders themselves 
(see troubleshooting, Table 4, p. 32).  
 
Option B: 
anti-X (100 µg/ml stock)  0.4 µl 
cognate Fab-Alexa 647 (200 µg/ml stock, as supplied) 0.4 µl  
were mixed and incubated for 15 min at 37°C, then chilled on ice and diluted with:  
AD-buffer   2.4 µl 
Lysate, anti-Y, and anti-anti-Y were added as above in option A, and controls were 
created accordingly.  
 
The labelling ratio of Fab:primary antibody was 6:1, corresponding to the maximal 
ratio recommended by the manufacturer for the Zenon-labelling system. Lower ratios 
were tested but proved less suitable. In contrast to the manufacturer’s instructions for 
labelling of primary antibody with Fab-fragments, preincubation for 5 min at RT was 
not sufficient. 
 
Option C:  
Mass-tag FCS was only employed for the detection of the interaction between ZAP70 
and phosphorylated CD3ε or CD3ζ. Both ZAP70-YFP and endogenous ZAP70 were 
used. In mass-tag FCS, all reagents that may give rise to large, slowly diffusing 
molecular aggregates must be avoided. Therefore, again monovalent labelled Fab-
fragments were employed instead of bivalent secondary antibodies. For endogenous 
ZAP70, sample setup was as follows: 
 
anti-ZAP70 (100 µg/ml stock)  0.4 µl 
cognate Fab-Alexa 647 (200 µg/ml stock, as supplied) 0.4 µl  
were mixed and incubated for 15 min at 37°C, then chilled on ice. Then was added:  
AD-buffer   1 µl 
clarified cell lysate  20 µl 
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biotinylated anti-CD3ε (75 µg/ml stock) 1.6 µl 
streptavidin-nanobeads (as supplied)  3 µl 
 
In lysates containing ZAP70-YFP, the endogenous fluorophore was used, anti-ZAP70 
and the secondary Fab-fragments were omitted, and anti-CD3ζ or anti-CD3ε and 
ProteinG-nanobeads were employed at 3-fold lower concentrations.  
 
Samples were set up in separate reaction tubes and incubated on ice for 16 h. Setup 
directly in the measurement carrier was avoided, as prolonged exposure to room 
temperature (i.e. for the last samples that were measured in a multiwell plate) was 
observed to influence measurement results. 
4.1.2 FCS and FCCS measurement and data evaluation 
For measurements, the same intrumental hardware as described in chapter 3.6 (p. 27) 
was used. Alexa488 was excited by the 488nm line of an argon ion laser and detected using 
an infrared-blocking 500-550 nm bandpass filter. Alexa633, Alexa647 and Cy5 were excited 
by a 633 nm helium neon laser and detected using a 650 nm longpass filter. A dichroic 
beam splitter at 610 nm separated fluorescence from Alexa488 and the respective red 
fluorophore. After warming up the lasers, the calibration of the instrument for cross-
correlation measurement in the relevant channels was checked(83). Each sample was kept 
on ice until immediately prior to measurement. For measurement, samples were 
transferred into a 384-well glass bottom plate (175 µm glass thickness; M-plates, cat.-no. 
60200, MMI, Glattbrugg, Switzerland) already mounted on the microscope stage. 
Measurement parameters were optimised using the respective control samples. For 
FCCS-measurements, excitation powers of both lasers were adjusted to yield comparable 
counts-per-molecule for the red and green particles. At the same time, laser powers were 
adjusted to yield fluorescence excitation near saturation, in order to optimise the signal-to-
noise ratio by ensuring optimum specific signal from the fluorophores over background 
noise resulting e.g. from cell lysate constituents with low autofluorescence 
10 measurements of 15 s duration each were recorded for all experimental conditions 
(see troubleshooting, Table 4, p. 32). The fluorescence fluctuations were correlated on-line. 
The software of the ConfoCor2 was used for fitting the auto- and cross-correlation 
functions. Fit functions for cross-correlation functions accounted for one diffusing species. 
All 10 individual cross correlation functions were fitted separately.  
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Table 4: Troubleshooting for protein complex detection by FCCS and indirect immunolabelling. 
Problem Possible reason Solution 
No cross-correlation is detected, 
although the proteins are known 
to interact. 
a) The concentration of the target 
complex in the lysate is higher 
than the concentration of the 
antibodies for labelling. 
Consequently, only a very small 
fraction of doubly labelled 
particles is formed. 
b) The concentration of the target 
complex in the lysate is too low to 
give rise to a detectable fraction of 
doubly labelled particles. 
c) The interaction of the proteins 
masks an epitope required for 
antibody recognition. 
a) Prepare a less concentrated 
lysate(145). 
 
 
 
b)Prepare a more concentrated 
lysate. 
 
 
c) Use an alternative antibody. 
 
 
High cross-correlation amplitudes 
already in control sample. 
Some of the reagents crossreact. Identify the culprit by cross-
correlation measurements of 
samples  
• containing no primary 
antibodies (secondaries 
interact) 
• containing only either one 
primary antibody (one of the 
secondaries cross reacts with 
the included primary) 
Particle numbers derived from 
autocorrelations in red and green 
channels differ strongly and the 
autocorrelation function of the 
fluorophore in excess indicates 
the presence of a fast-diffusing 
species. 
Free fluorophore is present in the 
stock solutions of the secondary 
reagents. 
Use a different secondary reagent, 
or try to separate the labelled 
reagent from the free fluorophore 
by size exclusion 
chromatography. 
Presence of relatively few, very 
slowly diffusing and bright 
particles, resulting in an 
inhomogeneous set of cross-
correlation amplitudes in 
repeated measurements. 
(see Table 2). 
Excessive formation of immuno-
complexes between individual 
primary and secondary anti-
bodies. Some primary anti-bodies 
may have individual epitopes 
that are more ractive with the 
(usually polyclonal) secondaries. 
Use monovalent secondary 
reagents (e.g. Fab fragments) 
instead of bivalent secondary.   
 
The total measurement time per 
sample may need to be optimised.   
If the fraction of doubly labelled 
particles in the sample is very 
low, longer total measurement 
times may be needed to stabilise 
the mean cross-correlation 
amplitude. 
If the fraction of doubly labelled 
particles is high, shorter 
measurement times per sample 
will be sufficient. 
Use e.g. 10 x 30s. 
 
 
 
 
Use e.g. 10 x 7 s. 
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The amplitude of the cross-correlation function was the only fitted parameter used 
for further analysis. Means and standard deviations of cross-correlation amplitudes and t-
tests for comparison of the means were calculated in Excel (Microsoft). For combination of 
data from multiple independent experiments, individual data sets were internally 
normalised to one experimental condition.  
Autocorrelation functions from mass-tag FCS were compared after normalisation to 
an amplitude of 1. In order to rapidly assess the presence of slowly diffusing particles 
from the autocorrelation functions, a fitting formalism accounting for only one diffusing 
species was sufficient. 
4.1.3 Anticipated results for FCCS 
Sample data for the detection of the pervanadate-induced interaction of PLCγ1 with 
LAT and the titration with the inhibitory peptide LATpY132 (also shown in Figure 31, p. 
80) is presented in Table 5. Cross-correlation amplitudes increase from a minimum of 
1.001 (no interaction). No cross-correlation is detected in the lysis buffer control (control) 
and in the lysate of resting cells (resting). The mean cross-correlation amplitude is 
significantly higher in the lysate of PV-stimulated cells (+PV) than in the lysate of resting 
cells and decreases again upon titration of the inhibitory LATpY132 peptide (PV + various 
concentrations). Statistical analysis is performed by one-tailed Student’s t-tests assuming 
unequal variances. Table 6 lists the mean autocorrelation amplitudes from the red and 
green channel determined in the same experiments. 
Sample data comparing labelling by whole bivalent secondary antibodies  (according 
to option A) and labelling by Fab-fragments (option B) is shown in Table 7. The 
pervanadate-dependent formation of the SLP76-PLCγ1 interaction is detected. In both 
setups, the increase in cross-correlation amplitudes upon PV-stimulation is obvious and 
significant. However, in the sample containing labelled IgG as a secondary binder for anti-
SLP76, the individual values in the set of 10 measured cross-correlation amplitudes vary 
widely. This is due to the occurrence of large immunocomplexes which introduce 
irregularities into the fluorescence fluctuation that stochastically affect the cross-
correlation amplitude. In the samples using labelled monovalent Fab-fragments as 
secondary binders for anti-SLP76, cross-correlation amplitudes of individual 
measurements vary less. 
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Table 5: Cross-correlation amplitudes of the interaction of PLCγ1 with LAT. Indirect 
immunolabelling was performed using anti-LAT (mouse monoclonal IgG1), goat anti-mouse IgG-
Alexa488, anti-PLCγ (rabbit polyclonal IgG), goat anti-rabbit IgG-Alexa633. Samples were lysis 
buffer (control), lysate of resting cells (resting), lysate of PV-stimulated cells (PV), lysate of PV 
stimulated cells with titration of inhibitory peptide (PV + various concentrations) 
repeated 15s 
measurements 
control resting PV PV +
50 nM 
PV +
100 nM 
PV +
200 nM 
PV + 
500 nM 
PV + 
1 µM 
PV +
10 µM 
1 1.006 1.003 1.014 1.012 1.008 1.015 1.007 1.001 1.001 
2 1.001 1.009 1.017 1.018 1.019 1.007 1.008 1.003 1.001 
3 1.001 1.003 1.012 1.001 1.008 1.008 1.012 1.002 1.001 
4 1.010 1.001 1.012 1.018 1.013 1.009 1.017 1.006 1.005 
5 1.001 1.001 1.010 1.016 1.011 1.018 1.018 1.001 1.001 
6 1.001 1.008 1.014 1.017 1.003 1.015 1.008 1.030 1.001 
7 1.001 1.001 1.017 1.039 1.013 1.024 1.014 1.001 1.001 
8 1.001 1.001 1.032 1.011 1.011 1.006 1.001 1.006 1.001 
9 1.001 1.001 1.012 1.037 1.014 1.023 1.012 1.012 1.001 
10 1.001 1.006 1.046 1.034 1.014 1.029 1.006 1.001 1.001 
mean 1.002 1.003 1.019 1.020 1.011 1.015 1.010 1.006 1.001 
stdv 0.003 0.003 0.011 0.012 0.004 0.008 0.005 0.009 0.001 
p-value of t-test versus 
control 
2.4 E-1 7.1 E-4       
p-value of t-test versus resting  1.1 E-3 9.2 E-4 1.1 E-4 4.5 E-4 1.5 E-3 1.8 E-1 4.3 E-2 
Table 6: Means and standard deviations of autocorrelation amplitudes for the same titration 
experiment as in Table 5. 
Channel control resting PV PV +
50 nM 
PV +
100 nM 
PV +
200nM 
PV + 
500nM 
PV + 
1µM 
PV +
10µM 
633 nm mean 1.15 1.15 1.16 1.15 1.17 1.18 1.17 1.17 1.16 
stdv 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.01 
488 nm mean 1.84 1.83 1.75 1.89 1.74 1.81 1.76 1.82 1.75 
stdv 0.09 0.12 0.10 0.21 0.09 0.14 0.06 0.08 0.11 
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Table 7: Cross-correlation amplitudes for the pervanadate-dependent PLCγ1-SLP-76 interaction. 
Indirect immunolabelling were perforemd using anti-PLCγ1 (rabbit polyclonal IgG), goat anti-
rabbit IgG-Alexa488, anti-SLP-76 (mouse monoclonal IgG 2a) and either goat anti-mouse IgG-
Alexa633 or goat anti-mouseIgG 2a Fab-Alexa647. Samples were lysis buffer (control), lysate of 
resting cells (resting), lysate of PV-stimulated cells (+PV). 
anti-mouseIgG IgG-Alexa633 anti-mouseIgG2a Fab-Alexa647  
 
repeated 15-s measurements  control resting + PV 
 
control 
 
resting 
   
    + PV 
1 1.001 1.006 1.425 1.006 1.007 1.069 
2 1.001 1.039 2.134 1.005 1.005 1.043 
3 1.002 1.004 1.035 1.006 1.010 1.025 
4 1.009 1.026 1.425 1.001 1.008 1.037 
5 1.005 1.007 1.377 1.006 1.012 1.022 
6 1.001 1.010 1.076 1.003 1.011 1.022 
7 1.001 1.012 1.286 1.008 1.012 1.051 
8 1.006 1.005 1.472 1.004 1.018 1.043 
9 1.008 1.003 1.231 1.007 1.007 1.031 
10 1.006 1.006 1.401 1.004 1.010 1.061 
mean 1.004 1.012 1.386 1.005 1.010 1.040 
stdv 0.003 0.011 0.287 0.002 0.003 0.015 
p-value of t-test versus control  3.4 E-2 1.6 E-3  1.0 E-3 3.3 E-5 
p-value of t-test versus resting   1.8 E-3   9.4 E-5 
 
 
4.2 Protein complex detection on peptide microarrays 
Susann Wolf and Wilfred Hummel advanced the procedures for the generation and 
incubation of peptide microarrays in their diploma theses (146,147). 
4.2.1 Generation of peptide arrays 
In early stages of the work, cover slips were used as array substrates, and surface 
functionalisation was carried out in-house (148). In brief, cover slips (BK7, type 1, 12 mm 
diameter; Marienfeld, Lauda-Königshofen, Germany) were cleaned by sonication in an 
aqueous solution of Extran MA01 (Merck, Darmstadt, Germany)/water (1:4, v/v) for 5 min 
followed by 20 min of sonication in piranha solution, a freshly prepared mixture of 6 
volumes H2SO4 with 5 volumes of 30 % (v/v) H2O2. For silanisation cover slips were 
covered with 40 µl of (3-glycidyloxypropyl)trimethoxysilane (Fluka), placed in an airtight 
container, and incubated at room temperature for 6 h, followed by rinsing with acetone. 
Immediately after silanisation, four arrays of 3*3 peptides were spotted with 300 µm 
centre-to-centre spacing onto the dry cover slips.  
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Later on, 16 identical arrays of up to 9*9 spots per array were spotted on epoxy-
activated glass slides (Nexterion Slide E, Schott, Jena) with a fluorescein labelled control 
peptide for orientation. Per peptide, duplicate spots of 1.2 nl each were spotted with a 
centre-to-centre spacing of 500 µm (147). 
For spotting, peptides were freshly diluted from 3 mM DMF stock solutions to a 
spotting concentration of 100 µM in 0.1 M phosphate buffer (pH 8.0). A GeSiM NP2.0 
nanopipettor (GeSiM, Dresden, Germany) was used, maintaining 70% air humidity in the 
spotter casing and cooling the target support to 15 °C. After the spotting process, slides 
were left in the closed spotter casing for 30 min. Afterwards, slides were covered with 
O,O’-bis(2-aminopropyl) polyethylene glycol 800 (Fluka) and incubated at 70 °C for 16 h to 
quench the remaining reactive epoxy groups. After cooling, slides were rinsed with 
deionised water, dried under airstream, and stored at 4°C. 
4.2.2 Incubation and scanning of peptide arrays 
Cover slips with peptide arrays were mounted in a custom-made open measurement 
chamber with the coated surface up, allowing incubation directly on the stage of the 
confocal laser scanning microscope (Carl Zeiss, Göttingen, Germany). 100 µl of cell lysate 
or antibody solutions were used for incubation on each cover slip. After addition to the 
cover slip, the solution was mixed by pipetting up and down several times. Incubation 
was carried out for 3 min for the lysates and for 15 min for antibodies. Antibodies were 
diluted to 5 µg/ml for anti-ZAP70, to 15 µg/ml for anti-phosphotyrosine  and to 2.8 µg/ml 
for Cy-5 labelled goat-anti-mouse-antibody in PBS-Tween/BSA. Between each incubation 
step, arrays were washed twice with PBS-Tween. Images of the arrays in the last washing 
buffer were acquired at a resolution of 512 x 512 pixels using a Plan-Neofluar 10 x 0.3 NA 
objective. YFP was excited with the 514 nm line of an argon-ion laser and detected using a 
BP530-600 nm band pass filter, Cy5 was excited with the 633 nm line of a helium neon 
laser and detected using an LP650 nm long pass filter. 
For peptide arrays on slides, slides were washed with lysis buffer and dd H2O and 
dried by air-stream. A 16-well clip-on frame (ProPlate Multiarray System, Molecular 
Probes, Eugene, Oregon) was sandwiched to with the slide to create a separate incubation 
chamber for each array. Arrays were blocked with 1% Top-Block (Fluka) in PBS for 1 h 
and washed with PBS-Tween/BSA. Originally, arrays were incubated with 200 µl cell 
lysate per chamber at 4°C for 1 h (147). In oder to minimise sample consumption, lysate 
incubation volumes were decreased to 50 µl, after a pilot experiment had shown that 
signals were independent of the lysate volume, in accordance with the ambient analyte 
theory(112) (Figure 5).  
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Figure 5: Net fluorescence of anti-PLCγ1 immunostaining on peptide arrays after incubation with 
lysate of PV-stimulated Jurkat cells. Different volumes of lysate were used per array, either 50 µl, 
100 µl or 200 µl. 
After lysate incubation, the arrays were washed with PBS-Tween/BSA, incubated 
with 2 µg/ml primary antibody at room temperature for 15 min, washed again with PBS-
Tween/BSA, and incubated with 1 µg/ml secondary antibody at room temperature for 10 
min (146). Per array, two primary antibodies were used, one from mouse, one from rabbit. 
Secondary antibodies were goat-anti-mouse-Alexa546 and goat-anti-rabbit-Alexa633 
(Molecular Probes/Invitrogen). For each primary antibody used, a negative control was 
carried out by immunostaining on an array without prior lysate incubation (Figure 6). 
Subsequent to staining, arrays were washed with PBS-Tween/BSA, rinsed with dd H2O, 
and dried by an air-stream (147). Dried slides were scanned on a confocal microarray 
scanner (ScanArray, Perkin Elmer, Rodgau-Jügesheim, Germany) with a lateral resolution 
of 10 µm, equipped with a 543 nm and a 633 nm laser. Sequential scans for Alexa546 and 
Alexa633 were taken to record both channels. 
4.2.3 Data analysis 
For evaluation of arrays on coverslips scanned wet on the LSM, the functionalised 
spots and the surrounding background were defined as separate areas-of-interest and the 
mean intensity within the respective area-of-interest was determined using Image Pro Plus 
4.5 (Media Cybernetics Inc., Silver Spring, USA). The net fluorescence F was calculated by 
subtracting the mean intensity of the background from the mean intensity of the respective 
spot. The net fluorescence over equally functionalised spots was averaged (149). 
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Figure 6: Peptide microarrays incubated with mouse anti-ZAP70 and anti-mouseIgG-Alexa546 
after incubation with A) BSA in lysis buffer (Control array), B) lysate of resting Jurkat cells, C) 
lysate of PV-stimulated Jurkat cells. Upper pairs of circles: immobilised phospho-ITAM-peptide 
CD3pY72/83. Lower pair of circles: polyproline motif peptide UBP403. To correct for signals 
resulting from crossreactivity of the anti-ZAP70 antibody, respective spot intensities were 
calculated: B – A and C – A. While low crossreactivity with spotted peptides was observed for most 
antibodies, the depicted anti-ZAP70 displayed particularly strong and promiscuous crossreactivity. 
 
For evaluation of slides scanned on the array scanner, resulting 16 bit greyscale tif 
files were further processed using ArrayProPlus (Media Cybernetics). In order to remove 
detector shot noise and speckles originating from dust on the arrays, images were first 
filtered using the ‘despeckle’ function which replaces pixels deviating by more than a 
certain value from their neighbouring pixels with the median of the neighbourhood. A 
filter kernel of 7x7 pixels and a threshold of 15 were used. Images were then overlayed 
with array grids, using fixed cell diameters of 30 pixels. The local background of each cell 
was defined as a ring of 3 pixel width, with an offset of 3 pixels around the cell. Net values 
were calculated by subtracting the local background from the cell content. Cells were 
identified by a description file with identical names for duplicate spots on the same 
subarray. The output data table contained net average values for cells with identical 
names.  
Data tables were copied into Excel (Microsoft) for further processing. First, negative 
net values (as occasionally resulted from unspecific binding around the spot area 
functionalised with peptide) were set to 0. From signals of each peptide spot and 
incubation condition, the respective signal of the antibody control was subtracted (Figure 
6). If a negative value was the result, it was set to 1, in order to enable further batch 
calculations. Corrected signal intensities of the stimulated conditions were divided by the 
corrected signal intensity of the unstimulated condition from respective peptide spots, if at 
least one of the values was above a certain threshold. Theses thresholds were employed in 
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order to filter out error-prone ratios resulting from division of one small value by another. 
Thresholds were established empirically (Figure 7): Various threshold values were set, e.g. 
at 10, 100 and 1000, defining intensity ranges from 10 to 100, 100 to 1000 and larger than 
1000. Ratios of signal intensities on corresponding peptide spots were calculated and 
assigned to an intensity range, depending on the value of the higher of both signals in the 
ratio. While ratios assigned to the intensity-range 10-100 proved unreproducible between 
repeated experiments, ratios assigned to the intensity range 100-1000 were reproducible in 
many cases. Ratios assigned to intensity range >1000 were highly reproducible (Figure 7). 
For PV-stimulation experiments, a threshold of 100 was used, for antibody-stimulation, a 
threshold of 50 was used. 
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Figure 7: Establishment of signal intensity treshholds for the evaluation of microarray data. Ratios 
of signals from lysates of PV-stimulated versus resting Jurkat cells are depicted in various colours, 
if either the numerator or the denominator of the ratio exceded a certain threshold: Black: one of the 
signals > 1000; grey: one of the signals > 100 but < 1000; white: one of the signals >10 but < 100.  
 
Results and Discussion 
 40
5 Results and Discussion 
5.1 Peptide microarrays for the detection of protein interactions in cellular 
signal transduction 
The experiments presented in chapter 5.1.1 were carried out together with 
Martin Elbs and Karsten Köhler, and the content of this chapter is derived from a 
published manuscript (149). The experiments presented in 5.1.3 were carried out with 
Karsten Köhler, and the content of chapter 5.1.3 is derived from an unpublished 
manuscript written together with Karsten Köhler. 
5.1.1 Pilot experiments 
5.1.1.1 Detection of changes in the availability of binding domains 
We realised that microarrays of peptides corresponding to protein interaction 
motifs (9) may provide a specific means for detecting the signalling-dependent 
masking or unmasking of binding sites. If, inside a cell, a protein engages in a 
molecular interaction, the binding domain involved in this interaction is masked. 
Complex formation should therefore decrease the amount of protein available for 
binding to the microarray after lysis (Figure 8). Peptide arrays have been employed 
already to profile the structural requirements of the binding of protein domains (12,11). 
For interaction motifs involving posttranslational modifications, such as 
phosphorylation, peptide microarrays are advantageous compared to protein 
microarrays. Amino acids carrying posttranslational modifications can be 
incorporated in a site-specific manner by organic synthesis procedures. For the 
detection of protein-peptide interactions, purified recombinant proteins as well as 
crude cell lysates (150) have served as the source for protein.  
In order to validate our concept, the activation dependent interaction of the 
tyrosine kinase 70 kDa ζ-associated protein (ZAP70) with the T-cell receptor (TCR)-
associated CD3ζ-chain, was selected as a model system (151). ZAP70 consists of an N-
terminal tandem SH2 domain and a C-terminal tyrosine kinase domain (Figure 1, p. 
6). In resting cells, this protein is located throughout the cell (152). Crosslinking of the 
TCRs by MHC-peptide complexes on an antigen-presenting cell leads to the 
phosphorylation of several tyrosine residues within immunoreceptor tyrosine-based 
activation motifs (ITAM) of the CD3ζ-chain (28).  
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Figure 8: Schematic of the application of peptide microarrays for detecting the masking of 
binding sites. Peptide microarrays are generated from peptides that correspond to motifs 
interacting with binding domains of signalling proteins. Recruitment of a protein into a 
complex masks a binding site on the protein, which is therefore no longer available for 
interaction with the microarray. Consequently, those proteins engaging in a molecular 
interaction will yield weak signals on the microarray. The binding of proteins may be 
detected in parallel by immunofluorescence, employing cocktails of primary antibodies. The 
pattern of proteins bound to the microarray reflects the pattern of molecular interactions 
inside the cells. 
The bis-phosphorylated CD3ζ ITAM peptide motif acts as a high-affinity 
docking site for the tandem SH2 domain of ZAP70 and recruits ZAP70 to the plasma 
membrane. Using plasmon resonance spectroscopy, an apparent dissociation 
constant of 2.0 ± 0.5 nM was reported for this interaction (21). Once incorporated into 
the TCR complex, ZAP70 becomes phosphorylated and fully activated and initiates a 
series of downstream signalling events (36). 
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Because of its relevance for the propagation of the TCR signal, the bis-
phosphorylated CD3ζ ITAM motif (pITAM) was selected to probe for the masking of 
signalling domains using a peptide microarray approach (Figure 8). The non-
phosphorylated counterpart (ITAM) served as a control for the specificity of binding. 
Both peptides were synthesised as peptide amides with an N-terminal cysteine 
residue for the covalent immobilisation on epoxy-activated surfaces. Ahx served as a 
spacer. Fluo-Ahx-KAA was employed as a control for surface chemistry and 
spotting. This peptide was immobilised via the ε-amino group of the lysine side-
chain. Microarrays of the peptides were generated on cover slips by nanopipetting 
subnanoliter volumes of solutions of the peptides. In initial experiments, ZAP70-
containing cell lysates were prepared from 3A9 mouse T-hybridoma cells stably 
overexpressing a ZAP70-YFP fusion protein as well as a fusion protein of the ZAP70-
binding CD3ζ-chain with the cyan fluorescent protein (CD3ζ-CFP). Binding of the 
ZAP70 fusion protein to the microarray was detected using a confocal microscope by 
recording the YFP fluorescence or after indirect immunofluorescence staining. 
For microarrays incubated with lysis buffer, only the fluorescence of the 
fluorescein-labelled control peptide could be detected. When microarrays were 
incubated with lysate from resting cells expressing ZAP70-YFP, the pITAM spots 
showed a bright fluorescence, indicating an interaction of the peptide with the 
ZAP70 tandem SH2 domains, whereas the ITAM spots remained dark (Figure 9 A, 
B). The specificity of the binding of ZAP70-YFP to the pITAM was further confirmed 
by preincubation of the lysate with 1 µM of free pITAM peptide to block available 
SH2 domains. Here, only the reference spots were visible (not shown). 
In comparison to lysates of resting cells, for lysates of cells treated with the 
tyrosine phosphatase inhibitor sodium pervanadate, binding of ZAP70-YFP was 
strongly reduced. The pITAM-associated net fluorescence was only about one 
quarter to one third of that detected for lysates of resting cells (Figure 9 C). Inhibition 
of tyrosine phosphatases leads to a strong phosphorylation of the transmembrane 
protein CD3ζ  by protein tyrosine kinases. On the whole-cell level the effect of 
pervanadate was apparent by the recruitment of ZAP70-YFP to the plasma 
membrane (Figure 10). The observed decrease in the microarray-bound signal is 
therefore consistent with the activation-dependent masking of the ZAP70 SH2 
domains and reduction of protein available for binding. A comparable reduction in 
signal was also observed when ZAP70-YFP binding was detected by indirect 
immunofluorescence using an anti-ZAP70 primary and a Cy5-labelled secondary 
antibody (Figure 9 D, E).  
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Figure 9: Activation-dependent binding of ZAP70 to peptide microarrays. All microarrays 
contained spots of a fluorescein labelled peptide, serving as a control for the surface chemistry 
(upper row in A–C), the unphosphorylated ITAM-peptide (middle row in A–C) and the 
bisphophorylated pITAM-peptide (lower row in A–C). (D–G) show the pITAM spots only. 
Microarrays were scanned by confocal fluorescence microscopy. (A) Microarray incubated 
with lysis buffer. Microarrays in (B, D, F) were incubated with lysates of resting cells, those 
in (C, E, G) with corresponding lysates of cells treated with sodium pervanadate. (B, C) 
Binding of ZAP70-YFP detected by YFP-fluorescence, (D, E) binding of ZAP70-YFP after 
indirect immunostaining for ZAP70 using Cy5-fluorescence. (F, G) Indirect 
immunostaining of endogenous ZAP70. The image contrast of each set of images (A–C; D, E; 
F, G) was optimised separately. The graph depicts the mean intensity of the background-
corrected fluorescence of each set of spots, normalised to the untreated condition for each 
experiment. Error bars reflect the mean deviation of the mean for each condition. 
 
Figure 10: Pervanadate-dependent cellular redistribution of ZAP70-YFP. In resting cells, 
ZAP70-YFP was evenly distributed (A). After incubation with pervanadate, ZAP70-YFP 
was recruited to the membrane-proximal region (B). Cell images were acquired with a 
sampling rate of 1024 x 1024 pixels using a C-Apochromat 63 x 1.2 NA water immersion 
objective 
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Figure 11: (A) Cellular content of ZAP70 and ZAP70-YFP before and after pervanadate 
treatment. Lysates of untransfected cells and cells overexpressing ZAP70-YFP and CD3ζ-
CFP, both treated with pervanadate or left untreated, were probed by western blot analysis 
for ZAP70. Equal amounts of protein were loaded in each lane. Endogenous ZAP70 runs at 
an apparent molecular weight of 70 kDa, ZAP70-YFP at approximately 100 kDa. (B) 
Validation of ZAP70 complex formation upon pervanadate treatment by fluorescence 
correlation spectroscopy (FCS). Autocorrelation functions were determined from lysates of 
cells overexpressing ZAP70-YFP and CD3ζ-CFP, treated with pervanadate or left untreated. 
The amplitudes of the autocorrelation functions were normalised to unity. As a control, FCS 
measurements were performed in lysates of pervanadate treated or resting cells expressing 
free YFP. 
Up to this point, the microarrays had succeeded in detecting an activation-
dependent reduction of protein binding using cells in which both binding partners 
were overexpressed. Western blot analysis revealed that the level of ZAP70-YFP 
fusion protein was about 2.5 times the level of endogenous protein in non-
transfected cells (Figure 11). In order to test whether the microarray approach was 
sensitive enough to detect the masking of binding sites in lysates of cells expressing 
endogenous amounts of both proteins, untransfected cells were employed. Binding 
of ZAP70 could be detected by immunofluorescence. Again, pervanadate treatment 
led to a significant reduction in the signal (Figure 9 F, G). 
To exclude a pervanadate-dependent degradation of total protein or specifically 
of ZAP70 as the cause of the reduced binding, lysates of pervanadate treated and 
resting cells were analysed for protein content and ZAP70 levels. Neither the total 
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protein content (data not shown) nor the ZAP70 content were influenced by 
pervanadate (Figure 11 A). Fluorescence correlation spectroscopy (FCS) in lysates of 
ZAP70-YFP expressing cells was employed to further substantiate that the reduction 
in binding reflected recruitment of ZAP70 into molecular complexes. FCS derives 
information on diffusion constants of fluorescent particles by the analysis of 
temporal fluctuations of a fluorescence signal (80,153). The decay time of the 
autocorrelation function reflects the size of the fluorescent particle. In a close 
approximation, the diffusion constant of a particle is inversely related to the cubic 
root of its mass (Eq. 10, Eq. 12, Eq. 13, p. 14). The intrinsic fluorophore YFP allows 
the sensitive detection of fusion proteins by FCS. Autocorrelation functions of 
ZAP70-YFP could be derived from fluorescence fluctuations recorded in crude cell 
lysates of pervanadate treated and resting cells. For pervanadate treated cells the 
autocorrelation curve was shifted towards longer autocorrelation times. The 
observed shift corresponded to a decrease of the diffusion constant by 45% and a 
sixfold increase in mass of the fluorescent particle, consistent with the recruitment of 
ZAP70-YFP into high-molecular weight complexes (Figure 11 B). No such change 
was observed for cells expressing free YFP instead of ZAP70-YFP.  
5.1.1.2 Determination of free and occupied binding sites of ZAP70 
Although a marked reduction of the pITAM-bound fluorescence was 
consistently found after pervanadate treatment, the reduction was stronger for cells 
overexpressing the fusion protein (Figure 9). This observation could either be due to 
the fact that the transfected cells also overexpressed the CD3ζ-chain or inherent to 
the detection method, i. e. YFP-fluorescence versus indirect immunofluorescence. In 
order to resolve this question we next asked to which degree the changes in signal 
on the microarray correlated with the availability of binding sites of ZAP70 in the 
cell lysate. Given such a correlation, microarray-based analyses would yield a 
quantitative measure of changes in molecular interactions in cellular signalling.  
In a first step, we took advantage of the ability of FCS to directly determine the 
concentration of fluorescent molecules. Lysates of resting cells expressing ZAP70-
YFP were prepared at different cell densities, ranging from 2 to 50 x 106 cells per ml 
lysate. The total protein content increased linearly with the cell density. The same 
was found for the ZAP70-YFP concentration, determined by FCS. By autocorrelation 
analysis, concentrations of the fusion protein in the cell lysates between 4 and 85 nM 
were derived. Moreover, the net fluorescence of ZAP70-YFP bound to pITAM spots 
on the microarrays was directly proportional to the concentration of ZAP70-YFP in 
the examined range (Figure 12 A, B). 
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Figure 12: Relation between the concentration of ZAP70 in the lysates of resting cells and 
array-bound fluorescence on pITAM spots after incubation on microarrays. (A) Lysates of 
resting cells expressing ZAP70-YFP were prepared at cell densities of 2, 5, 10, 20 and 50 x 
106 cells / ml lysate (black diamonds). The concentration of ZAP70-YFP was determined by 
FCS. Array-bound fluorescence of ZAP70-YFP increased linearly over the concentration 
range tested. Binding of ZAP70-YFP from a pervanadate treated lysate prepared at 10 x 106 
cells / ml was strongly reduced (open diamond). (B) pITAM spots on arrays incubated with 
lysates of 1, 10 and 50 x 106 cells / ml displayed an increasing fluorescence intensity of 
ZAP70-YFP, while indirect immunostaining against phosphotyrosine using a Cy5-labelled 
secondary antibody revealed that pITAM was not saturated by ZAP70-YFP. (C) Western 
blot analysis of endogenous ZAP70 from lysates of untransfected cells prepared at cell 
densities from 2 to 50 x 106 cells / ml. Equal volumes of lysate were loaded. Pervanadate 
treatment of the cells prior to lysis is denoted by pv. (D) ZAP70 western bands shown in (C) 
were quantitated by integrating their density and area. The ZAP70 content inceased linearly 
with the density of cells in the lysate. (E) Aliquots of the lysates depicted in (D) were 
incubated on arrays and the arrays indirectly immunostained for ZAP70. A correlation 
between ZAP70-content as determined by western blotting and intensity of the 
immunostaining on the array was established for lysates of resting cells (black diamonds). An 
array incubated with lysate from pervanadate treated cells (open diamond) showed a clear 
reduction of immunostaining. Error bars represent the mean deviation from the mean. 
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Figure 13: Western blot against ZAP70 after immunoprecipitation with anti-CD3ζ. Two cell 
lines were used, 3A9 cells, and 3A9 cells overexpressing ZAP70-YFP (3A9+ZY). Cells were 
either resting (-) or treated with pervanadate (+) before lysis. Expected molecular weights are 
70 kD for ZAP 70 and 99 kD for ZAP70-YFP. 
This calibration curve provided the basis to determine the decrease in the 
concentration of available binding sites upon treatment with pervanadate. In a lysate 
of 1 x 107 resting cells / ml the concentration of ZAP70-YFP was 19.9 ± 2.2 nM. From 
the reduction of the array-bound fluorescence after pervanadate treatment a 
reduction of unbound ZAP70-YFP to 7.1 ± 0.4 nM was calculated for a lysate of 
corresponding cell density (Figure 12 A). In order to confirm that the concentration 
determined by FCS corresponded to the concentration of ZAP70-YFP with available 
binding sites, we performed an immunoprecipitation of the CD3ζ-chain. Only after 
pervanadate treatment, ZAP70 and ZAP70-YFP coprecipitated with the CD3ζ-chain. 
In resting cells, no interaction with the CD3ζ-chain was detectable(Figure 13). 
At this point we were concerned, that the activation-dependent change in the 
level of microarray-bound ZAP70 and ZAP70-YFP could also have arisen from a 
competition of ZAP70 with other proteins in the lysate for which an activation-
dependent unmasking of binding sites had occurred. Such a competition would take 
place if binding of protein to the peptide spots was close to saturation. The linear 
dependence of array-bound fluorescence and ZAP70-YFP concentration to lysate 
densities of up to 5 x 107 cells / ml, five times the density employed for the 
quantification of activation-dependent changes, indicated that binding of ZAP70 to 
the microarray was clearly below saturation (Figure 12 A). The capacity of the spots 
for binding protein was further analysed by detection of remaining free pITAM after 
incubation with lysate. Here, we took advantage of the detectability of the pITAM 
peptide by indirect immunostaining, using anti-phosphotyrosine primary and Cy5-
labelled secondary antibodies. With increasing lysate concentration, Cy5-
fluorescence decreased by one half (Figure 12 B), demonstrating that pITAM peptide 
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was not a limiting factor for detecting activation-dependent changes in the masking 
of binding sites. 
Next, we intended to demonstrate that calibration curves can provide 
quantitative information on the masking of binding sites for endogeneous protein, as 
well. Lysates of untransfected resting cells were prepared at cell densities up to 5 x 
107 per ml lysate. The ZAP70 content of the lysates as determined by western blot 
analysis scaled linearly with the cell density (Figure 12 C, D). Again, the microarray-
bound fluorescence after indirect immunostaining correlated positively with the 
ZAP70 content. In contrast to the fluorescence of the ZAP70-YFP fusion protein, the 
correlation was non-linear (Figure 12 E). In the lysates of cells expressing ZAP70-
YFP, the fusion protein was overexpressed by 2.5-fold in addition to the endogenous 
protein (Figure 11) and the arrays were still not saturated at the highest lysate 
concentration tested. Therefore, the non-linear increase of immunofluorescence 
staining for endogenous ZAP70 most likely was not due to saturation.  
Rather, the immunostaining of bound ZAP70 had not reached equilibrium 
under the incubation conditions used (113). However, as long as incubation times are 
carefully controlled, antigen-antibody interactions can be used for quantitative 
detection in nonequilibrium assays (154). Especially for protein-peptide interactions 
with lower affinity, dissociation of bound protein after removal of the cell lysate 
would preclude a prolonged incubation to reach equilibrium. Even though the 
interaction of ZAP70 with the pITAM peptide is of rather high affinity, we intended 
to validate the method for conditions appropriate for interactions of lower affinity, 
therefore using short incubation times with primary and secondary antibody. The 
observed decrease in array-bound fluorescence for lysate from pervanadate treated 
cells corresponded to an 80% decrease of endogenous ZAP70 with unmasked SH2 
domains. 
Finally, we calculated absolute numbers of available ZAP70-YFP or ZAP70 
molecules per cell both in resting and in pervanadate treated cells by combining the 
information obtained from (i) determining the concentration of ZAP70-YFP in 
lysates of resting cells by FCS, (ii) the relative pervanadate-dependent reduction of 
free binding sites derived from the calibration curves, and (iii) the level of 
overexpression of fusion protein versus endogenous protein (Table 8). The total 
number of available ZAP70 molecules (ZAP70-YFP and ZAP70) in cells 
overexpressing the fusion protein could either be determined experimentally by 
western blot analysis or estimated from the overexpression level of the fusion 
protein. 
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Table 8: Pervanadate-dependent changes in the number of ZAP70 molecules with unmasked 
SH2 domains per cell. Numbers given relate to ZAP70-YFP for cells overexpressing the 
fusion protein and to endogenous ZAP70 for untransfected cells. 
 ZAP70-YFP with unmasked SH2 domains endogenous ZAP70 with 
unmasked SH2 domains 
 concentration / nM molecules per cell molecules per cell 
resting cells  19.9 ± 2.2 a)  (1.20 ± 0.13) x 106  4.8 x 105 c) 
PV treated cells  7.1 ± 0.4 b)  (0.43 ± 0.02) x 106  1.0 x 105 d) 
a) directly determined by fluorescence correlation spectroscopy (FCS) 
b) calculated from array-bound fluorescence using the calibration curve of array-bound fluorescence 
versus ZAP70-YFP concentration (Figure 12) 
c) estimated from the 2.5-fold overexpression of ZAP70-YFP over endogenous ZAP70 as determined 
by western blotting (Figure 11) 
d) estimated from array-bound fluorescence using the calibration curve of indirect immunostaining for 
array-bound ZAP70 versus integrated western band (Figure 12) 
 
5.1.1.3 Discussion 
The detection of the signalling-dependent masking of binding sites represents a 
valuable new protocol for the application of peptide microarrays in the analysis of 
cellular signalling processes. The protocol provides a significant shortcut to the 
detection of molecular interactions in comparison to established techniques such as 
coimmunoprecipitation. While the identity of the binding partner in the complex is 
not resolved, the parallel detection of binding events using microarrays 
functionalised with a multitude of peptides will provide a detailed description of the 
functional state of signalling proteins inside a cell. Given a repertoire of peptides 
that act as specific sensors for individual signalling proteins, each spot of a 
microarray may specifically report on the availability of a specific binding site.  
Moreover, through acquisition of calibration curves, e. g. by western blot 
analysis, quantitative information on the fraction of a protein recruited into a 
molecular complex is obtained. If cells expressing a fusion protein with a fluorescent 
protein are available, combination of the microarray-based approach with 
fluorescence correlation spectroscopy yields absolute figures on the change of 
available binding sites both in cells overexpressing the fusion protein and, through 
comparison of expression levels by western blotting, also in cells only expressing the 
endogenous protein. 
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The affinity range of protein-peptide interactions detectable by this technique 
will have to be determined. Interactions have to withstand multiple washing steps 
on the array in order to remain detectable. Compared to other interactions of 
proteins with peptide motifs, the interaction of the tandem ZAP70 SH2 domains 
with the bisposphorylated pITAM peptide is of rather high affinity. However, the 
applicability of peptide microarrays for the profiling of interactions with dissociation 
constants in the upper nanomolar to lower micromolar has already been 
demonstrated (11,12). In principle, protein microarrays might be used to monitor the 
masking of binding sites in a similar way. However, peptides as capture molecules 
afford a simple way to incorporate posttranslational modifications, which may be 
critical for binding. 
The results obtained for the interaction of ZAP70 with immobilised pITAM 
peptide encouraged the compilation of a collection of peptides with binding 
specificities for different proteins of the T-cell signal transduction cascade for further 
experiments.  
5.1.2 Additional interactions, 2-Colour detection 
As our pilot experiments revealed, phosphotyrosine motifs derived from SH2 
domain binding sites are attractive probes for the detection of the interaction status 
of a domain in a microarray format. To accordingly extend this detection principle, a 
number of pY peptides, as well as polyP motifs binding to SH3 domains, were 
chosen, based on the literature (Table 2, p. 24).  
In all further experiments, the human T-cell leukemia cell line Jurkat (or 
signalling-deficient derivatives of Jurkat) were used. Although these cells lack the 
lipid phosphatases SHIP and PTEN and have high levels of phosphatidylinositol 
3,4,5-trisphosphate (155), Jurkat cells are a widely used model for signal transduction 
in T-cells. Lysates of Jurkat cells were incubated on the peptide arrays and binding 
of the adapter proteins GADS and GRB2, of the scaffolding proteins LAT and SLP76, 
and of the signal transduction enzymes (most also with adapter functions) LCK, 
ZAP, cCBL, PLCγ1, PI3K-p85, VAV, and SHPTP2 was investigated by indirect 
immunofluorescence. 
16 identical peptide arrays were nanospotted per glass slide. A 16-well clip on 
frame allowed the incubation of individual arrays with different cell lysates and 
indirect immunostaining for bound proteins with different primary antibodies. In 
order to augment the number of proteins detectable per slide, in each well two 
proteins were detected simultaneously, using primary antibodies from mouse and 
rabbit and species-specific distinctly labelled secondary antibodies (Figure 14 A, B).  
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Figure 14: A) One coverslip holding 16 identical peptide microarrays, incubated with cell 
lysates and different antibodies for immunostaining. Each subarray was incubated with 
lysate of 106 Jurkat cells. Green: secondary immunostaining with anti-mouse-Alexa546; red: 
secondary immunostaining with anti-rabbit-Alexa633. B) Detailed view of the arrays used 
for determining background binding of anti-PLCγ1 and anti-LAT antibodies, and binding of 
PLCγ1 and LAT from resting and pervandate (PV) treated cells. Additionally, the 
background control for anti-GADS and anti-SLP76 is shown. C) Fluorescence intensities F 
derived for resting and PV treated condition were corrected for background binding of 
antibodies. Median values of 5 experiments are shown, if a minimum of 4 out of 5 
experiments produced a signal above threshold for either one of the stimulated or 
unstimulated condition (see Materials and Methods). 
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Figure 15: Two-analyte two-colour detection on peptide microarrays in comparison to one-
analyte one-colour detection. Lysates from resting Jurkat cells were employed. Secondary 
immunostaining was performed with goat anti-mouseIgG-Alexa546 against antibodies from 
mouse (antiLAT and antiLCK) and anti-rabbitIgG-Alexa633 against antibodies from rabbit 
(antiPLCγ1 and antiGRB2). Each panel shows signals obtained for binding of one protein to 
the array (labels below the panel) obtained in one-colour immunostaining (white columns) or 
in two-colour immunostaining in the presence of further antibodies (grey and black 
columns). 
The possibility of mutual influence of the signals (as might result from steric 
hindrance of antibody binding, or from crosstalk of fluorophores) was taken into 
account. In a pilot experiment, immunostaining signals obtained for proteins from 
Jurkat cell lysates with various combinations of two mouse antibodies (anti-LAT and 
anti-LCK) and two rabbit antibodies (anti-PLCγ1 and anti-GRB2) were compared 
with signals from incubations with individual antibodies alone. For all tested 
antibodies, the presence of further antibodies showed no influence on the detection 
on all immobilised peptides (Figure 15). Therefore, further experiments were carried 
out using two detection antibodies per array, thus increasing the information gain 
from each slide by a factor of two.  
Judged by the intensity of immunostaining on the array, proteins showed a 
strong preference for peptides representing binding motifs for the respective domain 
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subtype of the protein, notably peptides derived from known binding partners 
(Figure 14 C). For example, PLCγ1 contains an SHP/PLC type SH2 and 
correspondingly its signal on the peptide LATpY132 (SHP/PLC motif) was about 
twice as intense as on LATpY191 (GRB2/SFK/PLC motif) and nondetectable on 
LATpY226 (GRB2/SFK motif). The signal of GADS on the peptide SLP228 (atypical 
SH3 motif (133)) was about 300fold higher than on SLP179 (type2 SH3 motif). 
5.1.3 Dissection of signalling complexes on peptide microarrays 
5.1.3.1 Phosphorylation-dependent changes in interaction profiles  
To initiate signal transduction by protein phosphorylation, we employed the 
phosphatase inhibitor pervanadate(142). Lysates of resting or pervanadate-treated 
Jurkat cells were incubated on separate arrays (Figure 14 B, C) and ratios of signals 
from corresponding peptides were calculated (Figure 16 A).  
For interactions of SH2-proteins on pY peptides representing known binding 
partners, pervanadate induced a moderate signal decrease, as for GADS, GRB2, and 
PLCγ1 on the respective LATpY motifs. This decrease was in line with our 
previously demonstrated concept, that phosphorylation-dependent complex 
formation masks binding sites of proteins and therefore reduces binding to cognate 
immobilized phosphopeptides(149). Remarkably, for GRB2 an increase was observed 
on SIGpY437, representing an pY-motif subtype of the PLC/SHP subtype. For 
proteins directly binding to cognate polyP-motifs through SH3 domains, we 
observed only moderate signal changes, as for example for PLCγ1 binding to SLP179 
or Grb2 binding to GAB2-509 (72). In most cases, these changes were minor signal 
increases. In addition, most proteins lacking SH3 domains were also detected on the 
SH3-binding polyP peptides (Figure 16 A), suggesting that they were recruited to the 
array in a complex with a direct binding partner for an immobilized polyP peptide. 
Remarkably, signal increases for these proteins were much stronger than those of 
proteins for which direct binding was possible. Signals for which the subtype 
preference of the respective domain was violated could also originate from the 
binding of complexes rather than from direct interactions. For example, LAT, which 
has no interaction domains at all, displayed a stimulation-dependent median 74-fold 
increase of binding of on the polyP peptide SLP228. This binding could be mediated 
by an SH2/SH3 adapter like GADS or GRB2, which were also detectable, albeit with 
moderate median signal changes.  
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Figure 16: Changes in protein signal intensity on the peptide microarray upon treatment of 
Jurkat cells and derivative cell lines with sodium pervanadate. Peptides (horiontal) are 
plotted against proteins probed by immunostaining (vertical). Next to the proteins, their 
numbers of SH2 and SH3 domains are listed. Ratios of background-corrected fluorescence 
intensities were calculated for PV-treated to resting cells. A) Jurkat cells. The median ratio of 
5 experiments is shown, if a minimum of 4 out of 5 experiments produced a signal above 
threshold (see Materials and Methods). B) J.gamma1 cells and C) JCaM1.6 cells. The median 
ratio of 4 experiments is shown, if a minimum of 3 out of 4 experiments produced a signal 
above threshold. 
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The LAT-interactor PLCγ1 was detected on SLP228 with a median increase 
upon stimulation of 4400. Likewise, the increase of the GRB2 signal on SIGpY437 
could be explained by a phosphorylation-dependent interaction between GRB2 and 
SHPTP2, and binding of SHPTP2 to SIGpY437. On LATpY191, the median signal of 
GADS decreased to 0.7, while the medain signals of the GADS-interactor SLP76 and 
the SLP76-interactor PLCγ1 decreased to 0.2 of the unstimuated control (Figure 16 
A). Similar tendencies were found for GRB2 (0.7) and its binder CBL (0.3), which 
contains a PTB domain (38), unlikely to mediate direct interactions with LATpY191.  
The absolute signal intensities provided further evidence for the binding of 
protein complexes to the arrays (Figure 14 C). For lysates of resting cells, 
immunostaining for PLCγ1 was intense on SLP179 and PAK6 and negligible on 
SLP228 and GAB2-509. For lysates of pervanadate-treated cells, signals on SLP228 
and GAB2-509 were stronger than signals on SLP179 and PAK6. If a mere change in 
the availability of the SH3 domain of PLCγ1 was the reason for a signal increase, 
then the signal should increase uniformly on all peptides. The reversal in the order 
of signal intensities therefore suggests that a portion of PLCγ1 was contained in 
complexes recruited to the array via the SH3 domain of another protein.  
5.1.3.2 Dissection of complex architectures by peptide competition and titration 
Next we sought to confirm experimentally the binding of complexes on the 
array and to obtain information on the architecture of these complexes. On the 
SLP228 peptide spot, we detected GADS, LAT, and PLCγ1 (Figure 17 A). If the 
proteins were bound as a complex, then incubation with peptides corresponding to 
individual motif should selectively remove either one, two or all three proteins from 
the array We had shown previously, that the PLCγ1-LAT interaction was competed 
by incubation of lysates with the LATpY132 peptide and less effectively with 
LATpY191(145). Peptide concentrations for competition on the arrays were chosen 
accordingly. The signals of GADS, LAT and PLCγ1 were all sensitive to SLP228. 
Upon addition of LATpY191, the signals of LAT and PLCγ1 decreased, while the 
signal of GADS was not affected. In contrast to the LAT signal, the PLCγ1-signal was 
also sensitive to the LATpY132 peptide. Taken together, this suggested the following 
order of binding: SLP228 directly bound GADS, the SH2 of GADS bound LAT via 
LATpY191, LAT bound the SH2 of PLCγ1 via LATpY132 (131). Moreover, these results 
confirm that the binding of PLCγ1 to SLP228 is indirect. 
Peptide competition of the signals of GADS, SLP76 and PLCγ1 on the 
immobilized peptide LATpY191 enabled the dissection of the same set of 
interactions from yet another perspective (Figure 17 B): All proteins contain SH2 
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domains. Therefore, instead of binding as a complex, these proteins might bind the 
peptide independently. Detection of GADS, SLP76 and PLCγ1 was all sensitive to 
LATpY191. However, only SLP76 and PLCγ1 were sensitive to SLP228. PLCγ1 was 
also sensitive to SLP179, even though this peptide had some effect on all three 
proteins. Finally, the sensitivity of PLCγ1 to LATpY132 may suggest that further 
SH2-interactions stabilize the complex. In contrast to the LAT-containing complex 
described above, all three proteins were detected on LATpY191 also upon incubation 
of lysates of resting cells. Inhibitory peptides had similar effect in lysates of resting 
and pervanadate-treated cells (Figure 17 B), indicating the existence of a preformed 
complex of GADS, SLP76 and PLCγ1. However, the effect of all disrupting peptides 
on PLCγ1 was weaker in lysates from resting cells, suggesting that direct binding of 
PLCγ1 to immobilized LATpY191 accounted for a larger part of the signal than after 
stimulation. 
Titration with the peptides LATpY132 and LATpY191 yielded further 
information on the organisation of signalling complexes through comparison of 
titration curves obtained (i) for several proteins on the same array spot, or (ii) for one 
protein on a range of arrayed peptides (Figure 17 C). (i) For LAT and PLCγ1 on the 
SLP228 spot, signal losses upon addition of LATpY191 occurred with the same 
concentration dependence, while for LATpY132 only PLCγ1 dissociated, supporting 
the binding order inferred from the simple peptide competition experiment (Figure 
17 A). (ii) Upon titration with LATpY132, PLCγ1 fully dissociated from GAB2-509 
and SLP228 (atypical SH3-binding motifs), but only partially from PAK6 and SLP179 
(type 2 SH3-binding motifs), suggesting different modes of PLCγ1 binding. On 
SLP228, indirect binding of PLCγ1 as a part of a large complex can be assumed as 
shown by the competition experiment (Figure 17 A). SLP179 represents a favoured 
binding motif of the PLCγ1 SH3 domain. Still, titration with pY-peptides decreased 
the signal of PLCγ1, suggesting a role for the SH2-domain of PLCγ1 in the 
stabilisation of binding to the array.  
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Figure 17: Effects of competing peptides on the detection of proteins on the peptide array. 
Resting or pervanadate-treated (PV) Jurkat T-cells were lysed in the presence of the 
competitor peptides. A) Relative signal changes for PLCγ1, LAT, GADS on SLP228 for 
lysates of PV treated cells with and without addition of peptides LATpY191 (20 µM), 
LATpY132 (0.5 µM), SLP228 (20 µM), SLP179 (20 µM). Means and mean deviations from 
the mean of two independent experiments. B) Relative signal changes in the presence of 
competing peptides on spot LATpY191. Peptide concentrations as in A. Means and mean 
deviations from the mean of two independent experiments. C) Titration of lysates of PV-
treated cells with peptides LATpY132 and LATpY191. Overview of protein signals affected 
by peptide, with a signal decrease of more than 50%, indicated by X (upper left). Relative 
signal changes between lysates of PV-treated cells with varying peptide concentration and 
resting cells on peptide spot SLP228, from one representative experiment (upper right). 
Influence of peptide titration on the signal intensity of PLCγ1 on diffent peptide spots, means 
and standard deviation from the mean of two experiments (lower panels). 
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5.1.3.3 Effect of single protein deficiencies on the interactions network 
The titration experiments had revealed the significance of individual 
interaction motifs for the functional organisation of the network. Next, we examined 
the impact of a loss of a multidomain protein on the organisation of the network, 
using the PLCγ1-deficient Jurkat-derivative JGamma1 (139). 
Loss of PLCγ1 affected the formation of various complexes, notably on the 
preferential PLCγ1-interacting peptides. SLP76 on LATpY132 and LAT on SLP179 
became undetectable, supporting the role of PLCγ1 for their recruitment in Jurkat 
cells (Figure 16 B). To analyze the role of PLCγ1 in complex formation, ratios of 
signal intensities from JGamma1 to Jurkat lysates were calculated for resting and 
stimulated cells (Figure 18). For proteins supposed to bind directly to immobilised 
peptides (e.g. GADS and GRB2 on LATpY191 and SLP228), only marginal changes 
were observed. However, PLCγ1-deficiency strongly inhibited phosphorylation-
dependent recruitment of LAT to polyP peptides. Furthermore, in JGamma1-lysates, 
SHPTP2-signals on polyP-peptides were increased compared to WT Jurkat lysates, 
with no significant differences of SHPTP2 expression detected by Western Blot (not 
shown). As the SH2-domains of SHPTP2 and PLCγ1 share a common consensus 
motif, the lack of competing PLCγ1 may enable increased binding of SHPTP2. 
The Jurkat derivative cell line JCAM 1.6 displays no LCK activity, due to a 
mutation affecting the kinase domain of LCK (140). JCaM1.6 cells were used as a 
model for generally impaired TCR-downstream signalling capacity. For JCAM1.6 
cells (Figure 16 C), the predominant signal decrease observed on pY peptides for 
Jurkat cells (Figure 16 A) was largely missing, agreeing with the role of LCK in 
starting a phosphorylation cascade. Effects were observed for ZAP70, a binding 
partner of activation motifs phosphorylated by LCK, and for proteins further 
downstream the kinase cascade, such as the ZAP70 substrates SLP76 and LAT. 
PLCγ1 became undetectable on most polyP peptides, likely due to missing 
phosphorylated LAT and SLP76 as mediators of binding. By contrast, pervanadate-
dependent recruitment of SHPTP2 to polyP peptides was not affected. This suggests 
LCK independent, but phosphorylation-dependent formation of a complex between 
SHPTP2 and an SH3-SH2 adaptor protein.  
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Figure 18: Changes in protein signal intensity on the peptide microarray between PLCg1 
deficient JGamma1 cells and “wildtype” Jurkat cells, expressed as background-corrected ratio 
JGamma1/WT. Lysates of resting (-) and pervanadate-treated (+) cells were used. The median 
ratio of 4 experiments is shown, if a minimum of 3 out of 4 experiments produced a signal 
above threshold. 
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5.1.3.4 Stimulus-dependence and time course of protein interactions in T-cell 
activation 
We next employed the peptide arrays to profile the timecourse of protein 
complex formation in a more physiological model of T-cell activation. Jurkat cells 
were stimulated for variable times with stimulatory anti-CD3 (clone OKT3), 
costimulatory anti-CD28 (clone 9.3), or both. On the arrays, distinct and reproducible 
changes in signal profiles were obtained for PLCγ1, LAT, SLP76 and PI3K (Figure 
19). For PLCγ1, signal increases on polyP peptides were strongest after 2 min of CD3-
stimulation, and then diminished. Only on SLP228, CD28 stimulation alone induced 
slight increases in PLCγ1 recruitment. CD3-CD28 costimulation augmented signal 
increases compared to CD3 stimulation without affecting their kinetics. For LAT, 
analogous signals were observed for CD3 stimulation, suggesting fast pY-dependent 
complex-formation with PLCγ1 and corecruitment to the array. For SLP, signal 
decreases on LATpY peptides were detected upon CD3 stimulation. Interestingly, 
this decrease was most pronounced after 10 min of stimulation, indicating that 
recruitment of SLP76 to the LAT complex occurred with slower kinetics than the 
phosphorylation of LAT and recruitment of PLCγ1. In the presence of antiCD28, 
signals of detection antibodies from mouse could not be quantified because of high 
overall backgrounds, accounting for the data points missing for LAT and SLP. For 
PI3K, no systematic signal changes were observed upon stimulation with CD3 or 
CD28 alone, whereas costimulation led to a signal decrease. Pervanadate stimulation 
was conducted in parallel as positiv control, yielding signal changes consistent with 
the antibody effects. Pervanadate effects were weaker than in the experiments 
presented above (Figure 16). Antibody stimulation required preincubation on ice, a 
condition that apparently also affected pervanadate-dependent cell activation. 
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Figure 19: Signal changes on the peptide microarray following treatment of Jurkat cells with 
stimulatory antibodies against the TCR/CD3-complex (αCD3) and the CD28 coreceptor 
(αCD28) for different time points. Ratios of stimulated versus resting cells. In the presence of 
the stimulation-antibody αCD28, high overall backgrounds forbade quantification of signals 
of detection antibodies from mouse, accounting for missing data points for LAT and SLP76. 
Negative control by mock-stimulation with an isotype antibody (IgG), positive control by 
pervanadate (PV). Signals for the protein indicated on top of each column of graphs, derived 
from the peptide spot indicated in each graph. Means and mean deviations of the mean of 3 
experiments. 
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5.1.3.5 Discussion  
Signalling processes downstream of transmembrane receptors typically occur 
in a timeframe of minutes through rearrangement of a given repertoire of signalling 
components. While signal-induced fast degradation of single components may 
occur, the levels of most components remain unchanged and expression of further 
components is still far downstream. However, the molecular interactions of 
signalling components change significantly. We demonstrate how these changes in 
interaction can be detected in cell lysates using peptide microarrays. 
We have shown previously that changes in the availability of a protein domain 
involved in a signalling-dependent protein-protein interaction can be detected by a 
capture peptide probing for the availability of the binding domain (chapter 5.1.1) (149). 
This approach was now generalised for the parallel detection of different 
interactions. In addition, we exploit that proteins directly binding to capture 
peptides bring along their interaction partners, making microarrays a highly parallel 
variant of co-purification techniques. In a typical experiment (Figure 19), proteins 
bound by 24 capture peptides were probed with 8 different antibodies under 16 
different conditions, yielding 3072 data points for the analysis of interactions in T-
cell signalling using only 106 cells per array. In contrast to high throughput tag-based 
affinity purifications, the array-based approach does not require the introduction of 
recombinant components into the signalling network. Therefore, the molecular 
system under scrutiny is not already manipulated before the experiment begins. 
On the molecular level, inducible tyrosine phosphorylations trigger the onset of 
complex formation. Therefore, additional pY sites generated through stimulation 
compete for SH2-proteins with the pY peptides on the array, while the cellular level 
of polyP motifs is not changed through stimulation. This may explain a general 
trend we observed for stimulation-dependent signal changes on the arrays: On pY 
peptides, signal decreases were dominant, while on polyP peptides signal increases 
dominated. 
Especially on polyP peptides, we detected proteins without a cognate binding 
motif. Indeed, we were able to dismantle supposed complexes on the arrays in a 
stepwise and dose dependent manner through competition and titration with 
peptides corresponding to binding motifs between the proteins in the complex. This 
finding demonstrates, that detected proteins need not interact directly with the 
peptide, but may instead be brought along by another protein directly binding the 
peptide. 
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Figure 20: Schematic diagram for selected proteins detected on the arrays and their supposed 
hierarchy of binding based on the relative signal change upon pervanadate treatment of cells 
(represented by the colour of proteins, taken from Figure 16). The immobilised peptides are 
depicted at the basis of the protein stacks. White circles depict a phosphorylation-dependent 
binding motif, grey pentangle a polyP motif. 
In lysates of resting cells, we detected the presence of polyP-SH3 domain 
mediated preformed complex ‘nuclei’. For example, on LATpY132, representing a 
direct binding motif for PLCγ1, we observed stimulation-dependent decreases to the 
binding of PLCγ1 and SLP76 in Jurkat lysates. In lysates of PLCγ1-deficient Jurkat 
cells, both proteins were not detectable on LATpY132, suggesting PLCγ1-dependent 
recruitment of SLP76. For LCK-defective cells, both proteins were detectable, but 
their signals did not decrease upon stimulation. On LATpY191, corresponding 
observations were made for the preformed complex of GADS and SLP76. Taken 
together, these observations suggest that upon stimulation, the preformed 
complexes contributed to the assembly of larger, phosphotyrosine-dependent 
signaling complexes. 
We realized that complex architectures inferred from the peptide competition 
experiments were correlated to the different magnitudes of signaling-dependent 
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signal changes for the different proteins detected on a given peptide. The more 
distant from the peptide, the more pronounced was the relative signal change for the 
protein (Figure 17, Figure 20). Assuming a linear chain of protein-protein 
interactions, this observation can be explained by the potentiation of changes from 
one level of protein binding to the next: If each of the interactions contributing to a 
linear complex on the immobilized peptide (peptide-A-B-C) occurred with a 
different probability after stimulation (peptide-A changing x-fold, A-B changing y-
fold, B-C changing z-fold), then the chance to find the outermost protein C on the 
immobilized peptide would change x*y*z-fold. Per se, x, y, and z may each be larger 
or smaller that 1. While situations are conceivable where the increases and decreases 
balance, we found that the relative magnitude of signal changes as described above 
was a useful indicator of the interaction architectures. 
For the interplay of stimulation of TCR/CD3 and CD28 by stimulatory 
antibodies, our peptide microarrays allowed the analysis of timecourses of protein 
complex formation in a parallel manner. We demonstrate that the recruitment of SLP 
to the LAT-signalosome follows a different timecourse than the recruitment of 
PLCγ1. Recently, an analysis of phosphorylation kinetics in early T-cell signalling 
showed, that phosphorylaton of LAT-residues Y132 and Y191 reaches maximum 
levels within two minutes (45). Our data shows that the arrayed LATpY191 is 
maximally competed by its cellular counterpart after 10 minutes of stimulation, 
suggesting that LAT-phosphorylation is not the rate-limiting step for formation of 
the LAT-signalosome. Co-stimulation with anti-CD28 and anti-CD3 led to more 
distinct, and additional signal changes concerning PI3K, compared to CD3 
stimulation alone. This finding demonstrates the potential of the peptide 
microarrays for integrated network analysis in systems with multiple stimuli. 
Likewise, for the analysis of signaling systems missing single proteins, peptide 
arrays provide a means to uncover effects of molecular links on interaction 
subsystems. 
In conclusion, peptide microarrays provide a tool for the highly parallel 
analysis of protein-protein interactions in cellular signal transduction, bridging the 
gap between binding studies with single proteins and complex interactomics 
experiments. Quantitative analysis of signal changes upon stimulation and 
competition experiments provide a wealth of information on the functional 
organisation of protein complexes. This approach will benefit from the use of 
arrayed peptide libraries derived from the literature as well as by motif prediction 
(20,14). In combination with antibody libraries the simultaneous probing for all 
potential molecular interactions in a signalling network can deepen our 
understanding of signal transduction in a systems biological view. 
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5.2 FCS and FCCS for the detection of signalling complexes 
Parts of the data presented in this chapter have been published (145,144) 
 
The analysis of protein complexes still mainly relies on cell lysis followed by 
the application of biochemical techniques. A major advantage compared to 
intracellular techniques is that complexes of endogenous proteins can be detected, 
eliminating the need for the generation of fusion proteins and ensuring that complex 
formation cannot be disturbed by the respective tags. Moreover, in contrast to FRET 
and BRET, signals are directly correlated with a physical interaction of the proteins.  
The characteristic feature of classical biochemical analyses for protein complex 
analysis is the separation of the protein complex from the remaining cell lysate by 
affinity purification. Specific binders for one constituent of the complex are coupled 
to a polymer matrix. Washing of the matrix is necessary during separation, but 
obviously favours the dissociation of weakly interacting partners. Moreover, the 
further handling steps for complex detection, e.g. as required for western blotting, 
are cumbersome and time consuming, limit sample minimisation and complicate 
automation. Therefore, advances in biochemical methods for the analysis of protein 
complexes are still urgently needed.  
We consequently developed a separation free method for the rapid detection of 
interactions of endogenous proteins directly in crude cell lysates, combining high 
detection sensitivity with a minimum of handling steps and consumption of sample 
and reagents. FCS (Figure 21 A) and FCCS (Figure 21 B) were used for detection. 
 
 
Figure 21: Schematic of interaction analysis by FCCS and mass-tag FCS. A) Attachment of a 
mass-tag to a fluorophore-labelled particle slows down the diffusion of the particle, leading to 
a right shift of the autocorrelation function. B) Two spectrally distinct fluorophores attached 
to a diffusing particle give rise to a cross-correlation.  
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5.2.1 FCS of ZAP70-YFP in cells and lysates 
5.2.1.1 Cellular measurements 
In initial experiments, we attempted to characterise the stimulation-dependent 
recruitment of ZAP70-YFP to the TCR/CD3 complex by cellular FCS measurements. 
We used a cell line expressing ZAP70-YFP at a level of 2.5 times that of endogenous 
ZAP70 (149). To induce early steps of T-cell signalling, cells were incubated with 
sodium pervanadate (142). This phosphatase inhibitor shifts the balance of kinase and 
phosphatase activities, inducing the phosphorylation of CD3-subunits and thereby 
the binding of ZAP70 to the receptor complex at the plasma membrane (152).  
Upon pervanadate treatment, relocation of ZAP70-YFP from throughout the 
cell to the membrane was clearly visible by microscopy(149) (Figure 10, p. 43). FCS was 
carried out alternatingly in cells with and without addition of pervanadate to the 
incubation buffer over the duration of 60 min.  
When the confocal volume was placed directly on the membrane, a very strong 
initial bleaching was observed in pervanadate-treated cells, indicating that proteins 
recruited to the membrane were immobile on the timescale accessible to FCS-
measurements (not shown). While those fluorophores clearly corresponded to the 
ZAP70-YFP recruited to the membrane, in this case cellular FCS did not add 
significant information to the microscopic image.  
 
Figure 22: Intracellular diffusion times of ZAP70-YFP. Panels show independent 
experiments. Each value is the mean determined from repeated measurements in one 
individual cell. The number in parenthesis indicates how many of the 15 repeated 
measurements per cell could be fitted to a function corresponding to Eq. 17. The first 
measurement was routinely discarded, as it was compromised by bleaching of immobile 
molecules. Error bars indicate mean deviations from the mean. For pervanadate stimulation, 
pervanadate was added to the incubation buffer at time 0. Individual cells were measured one 
after the other, over a total incubation time of 60 minutes. 
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Figure 23: Decrease of cellular fluorescence during FCS measurements in individual cells. A-
C) Transmission and epifluorescence images of cells expressing ZAP70-YFP fusion protein 
before (B) and after (C) FCS measurement in the central cell. The bar denotes 5 µm. D) The 
visible decrease in fluorescence was reflected by a decrease in the number N of fluorescent 
particles derived from curve fits of sequentially recorded intracellular autocorrelation 
functions. The error bars indicate fitting errors. A monoexponential decay function was fitted 
to the data points in order to estimate the original N before photobleaching during 
measurements occurred. 
When the confocal volume was placed in the cytoplasm, the observed diffusion 
times of ZAP70-YFP did not reproducibly differ between pervandate-treated and 
resting cells (Figure 22).  
As most protein-protein interactions, the association of ZAP70 with CD3 
subunits has been originally deduced by co-immunoprecipitations in cell lysates 
(21,34)). Therefore, our next steps were to investigate, whether FCS could (i) detect 
complexes of ZAP70-YFP from crude cell lysates and (ii) provide information 
complementary to co-immunoprecipitation. 
To validate lysis, we compared ZAP70-YFP numbers measured in live resting 
cells and in lysates from resting cells. For intracellular measurements,the confocal 
volume was placed in a membrane-proximal region of the cell. Transmission and 
epifluorescence images were taken of the cells before carrying out FCS (Figure 23 A, 
B). 15 consecutive measurements of 10 s each were conducted. Afterwards, 
epifluorescence images were taken again, to ensure cells were still in position (Figure 
23 C). In cellular FCS, photobleaching was not negligible. Curve fits for the 
individual autocorrelation curves from 15 measurements according to Eq. 17 
revealed a continuous decrease of the number N of ZAP70-YFP molecules. Not all of 
the 15 autocorrelation curves recorded per cell could be analysed, probably due to 
microscale-movements of the cell. By plotting N against the total measurement time, 
the initial number N0 of particles at measurement time 0 could be inferred from 
fitting with a monoexponential decay function (156) (Figure 23 D). Using an estimate 
for the size of the confocal volume (Eq. 6) cytoplasmic concentrations of ZAP70-YFP 
were calculated. From the images taken of each analysed cell, individual cell 
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diameters were determined, and total numbers of ZAP70-YFP per cell were 
calculated assuming spherical cells with homogenous distribution of ZAP70-YFP. 
On average, 1.7*106 ± 0.5 *106 molecules of ZAP70-YFP were found per cell, agreeing 
well with the number inferred from FCS-measurement in lysate, which was 1.2 *106 ± 
0.1 *106 per cell(149) (see chapter 5.1.1). 
5.2.1.2 Measurements in lysates 
FCS was carried out in lysates of resting and pervanadate-treated cells. Cells 
expressing free YFP served as a control. For cells expressing ZAP70-YFP, three 
parameters changed with pervanadate treatment (Figure 24 A). First, the diffusion 
coefficient decreased, indicating incorporation of ZAP70-YFP into complexes of 
higher molecular weight (149).  
Second, the number of diffusing fluorescent particles decreased. As the total 
fluorescence in the lysates remained unchanged, this decrease was not due to a loss 
of ZAP70-YFP. Third, the brightness of ZAP70-YFP-containing particles (expressed 
in counts per molecule, cpm) increased.  
In comparison, pervanadate had no effect in lysates of control cells expressing 
free YFP. All results were evaluated for significance by Student’s t-test. For lysates of 
ZAP70-YFP expressing cells, p-values for changes upon pervanadate treatment were 
10-9< p < 10-6. In contrast, for lysates of cells expressing free YFP, p-values were larger 
by several orders of magnitude and differences were smaller than ± 1 standard 
deviation. The results were highly reproducible for independent experiments (not 
shown). Taken together, these changes indicated that signalling complexes 
containing more than one molecule of ZAP70-YFP were formed. By comparison of 
the cpm, the average number of ZAP70-YFP molecules per fluorescent particle was 
estimated to increase from 1 to 1.6 upon pervanadate treatment. As dimerisation of 
GFP-derivatives occurs with an approximate Kd of 100 µM (75), YFP and YFP-fusion 
proteins can be safely assumed to be monomeric at the nanomolar concentrations 
used in FCS. 
Approximate average MWs for the diffusing species were calculated (Table 9). 
The viscosity η of cell lysates was estimated from measurements of free YFP with the 
known molecular weight of 29kD. Prior to pervanadate treatment, the MW was in 
the range of 350 kDa. After pervanadate treatment the MW increased to 
approximately 1500 kDa. These results suggest that ZAP70-YFP was already 
incorporated into complexes in resting cells. 
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Figure 24: Detection of protein complexes in crude cell lysates by fluorescence correlation 
spectroscopy. A) Pervanadate-dependent formation of complexes containing ZAP-70-YFP. 
Black columns refer to lysates of pervanadate-treated cells, white columns to those of resting 
cells. Two cell lines were used, expressing ZAP-70-YFP (Z-Y) or free YFP (Y). For ZAP-70-
YFP, the diffusion coefficient D (left panel) and the concentration of fluorescent particles 
(expressed by the number N of particles in the detection volume, center panel) decreased 
while the particle brightness (expressed in cpm, right panel) increased upon pervanadate 
treatment. To account for different expression levels of ZAP-70-YFP and free YFP, N was 
normalised to 1 for the lysates of resting cells. B) Reversion of pervanadate-dependent 
complex formation by pITAM peptide (pI). pITAM or non-phosphorylated control peptide 
ITAM (I) were added to a final concentration of 1 µM to lysates of cells expressing ZAP-70-
YFP (-, no peptide). Error bars correspond to the standard deviation of 10 repeated 
measurements of one representative experiment. Numbers x above columns designate 10-(x+1) < 
p < 10-x in Student’s t-test. Corresponding data combined from three independent 
experiments is shown in the supplementary Fig. 1. C) Western blot against ZAP-70 in 
lysates of untreated (-PV) and pervanadate-treated (+PV) cells expressing ZAP-70-YFP. 
pITAM (+pI) was used at 1 µM. Equal amounts of total protein were loaded. 
To further exclude a pervanadate-dependent degradation of ZAP70 or 
unspecific loss of protein due to cell death prior to lysis, lysates were analyzed for 
total protein content (not shown) and ZAP70-levels (Figure 24 C). Neither was 
influenced by pervanadate treatment.  
ZAP70 is known to bind via its tandem SH2 domain to tyrosine-
phosphorylated ITAMs of CD3ε and ζ (21,34). A competitor peptide (also employed on 
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the peptide arrays, chapter 5.1, p.40) was used to test whether this interaction 
contributed to forming the observed complexes. This peptide, corresponding to the 
tyrosine-phosphorylated ITAM1 of CD3ζ (pITAM), partially reversed the effects of 
pervanadate stimulation. An unphosphorylated control peptide (ITAM) had no 
effect (Figure 24 B). Again, the level of ZAP70 and ZAP70-YFP was not altered 
(Figure 24 C). These results confirm the contribution of the tandem SH2 domain of 
ZAP70 to complex formation.  
However, while FCS has proven to be a method suitable for protein complex 
detection in microliters of cell lysate, the identity of the actual binding partner of 
ZAP-70-YFP had not been determined. Therefore the next step was to develop an 
approach for the FCS-based identification of interacting proteins. 
 
 
Table 9: Calculation of approximate molecular weights from diffusion times of ZAP70-YFP 
containing particles (according to Eq. 10, Eq. 12, and Eq. 13). Using the molecular weight 
and diffusion times of free YFP, the viscosity of the lysates was estimated as 1.8 10-3 Pa s. 
Lysate  τD / µs D / 10-7 cm2 s-1 M / kDa 
ZAP70-YFP, - PV 256 ± 25 2.4 ± 0.2 353   ±  105 
ZAP70-YFP, + PV 419 ± 43 1.5 ± 0.2 1550   ±  473 
YFP, - PV 126 ± 19 4.9 ± 0.7 42   ±    19 
YFP, + PV 105 ± 20 5.9 ± 1.1 25   ±    14 
 
 
 
5.2.2 Detection of signalling complexes in cell lysates by indirect immunolabelling 
Antibody-based detection of protein interactions benefits from the large and 
ever growing repertoire of specific primary antibodies that can be combined to probe 
for diverse pairs of interacting proteins. However, for monitoring protein-protein 
interactions by FCS-based techniques, the interaction partners have been in most 
instances directly covalently labelled, either by chemical conjugation to a 
fluorophore or by genetic fusion to a fluorescent protein. Although FCS has been 
used for characterisation of antigen-antibody interactions per se (157,158), to our 
knowledge only one example exists in which fluorescently labelled primary 
antibodies have been employed as a labelling tool in FCCS (159).  
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Figure 25: Detection of complexes by FCCS and mass-tag FCS, exemplified for the 
pervanadate-induced (+PV) interaction of ZAP-70 with CD3ε. A) For the detection of 
complexes containing a YFP-fusion protein of ZAP-70, a primary antibody against the 
possible interaction partner CD3ε and a matching secondary reagent were added to the 
lysate. This was (I) a Cy5-labelled secondary antibody or (II) a protein G-functionalised 
microbead. The interaction was detected (I) by the cross-correlation (cc) of YFP and the 
second fluorophore or (II) by the shift of the autocorrelation function towards longer diffusion 
autocorrelation times of YFP. B) For the detection of complexes of endogenous proteins, two 
sets of primary antibodies and matching secondary reagents were used. One secondary 
reagent introduced a fluorophore, the other one (III) a second fluorophore or (IV) a mass-tag. 
(A488, A647: fluorophores Alexa488, Alexa647) 
The introduction of an additional binding equilibrium, i. e. that of the antibody 
to its antigen, is a concern when using this strategy. Moreover, in order to fully 
exploit the benefit of antibody-based strategies for FCS and FCCS, the detection 
should be based on indirect immunolabelling to avoid the need for the direct 
labelling of primary antibodies. However, the presence of even more binding 
equilibria might compromise the detection of complexes. Here we show that 
contrary to these expectations, indirect immunolabelling represents a straight-
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forward, versatile and specific way to confer properties detectable by FCS or FCCS 
to proteins in lysates. 
Two approaches were followed: labelling of the interaction partners with with 
two spectrally different fluorophores for FCCS-detection, or, alternatively, labelling 
of one interaction partner with a fluorophare and the other one with a nanoparticle 
as mass tag for FCS-detection (Figure 21). Both approaches were initially established 
for the interaction of ZAP70-YFP with CD3ε and ζ. (Figure 25 A). 
5.2.2.1 Mass-tag FCS 
FCCS is instrumentally more demanding than FCS, as two lasers for excitation 
and two detectors are required, and spatial overlap of the detection volumes must be 
ensured. Additionally, fluorophores with little spectral overlap must be used to 
avoid FRET and cross-talk. Consequently, we first tested FCS as an alternative to co-
immunoprecipiation by indirectly immuno-labelling one protein in a complex with a 
fluorophore and the other one with a nanoparticle as mass-tag (160).  
In single channel FCS, interactions are detected by a shift of the autocorrelation 
function towards longer autocorrelation times τ, reflecting the smaller diffusion 
constants of complexes as compared to their constituents alone. Detectable shifts 
require a substantial mass increase. Binding of antibodies has been employed to 
analyze molecular complexes by FCS (161), however, for protein complexes the 
additional molecular weight of a primary antibody may not add sufficiently to the 
total molecular weight to allow a distinction based on shifts of the diffusional 
autocorrelation times.  
Colloidal paramagnetic nanoparticles of 50 nm diameter functionalised with 
proteinG or streptavidin were used. First, the influence of the presence of 
nanoparticles on FCS-measurements was assessed with a simple system, in which no 
interactions between the diffusing fluorophore rhodamine-6-G and the nanoparticles 
should occurr. While apparent numbers of fluorophores increased with the 
concentration of nanoparticles (as seen from the decrease of the autocorrelation 
amplitude, Figure 26 A), autocorrelation diffusion times τD remained constant 
(Figure 26 B). As changes in τD upon mass-increase due to interaction constitute the 
readout parameter for FCS-based complex analysis, this result demonstrated that 
shifts in tD should reflect binding to the n anoparticles and not an artefact caused by 
changes in the composition of the sample. 
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Figure 26: FCS in solutions with identical concentrations of Rhodamine-6-G and various 
dilutions of protein G nanoparticles to the stock product. A) Autocorrelation curves and B) 
standardised autocorrelation curves of 10 measurements each. 
 
Figure 27: Lysine functionalised with biotin and fluorescein (Fluo-K-Bio) employed as a 
fluorescent probe for FCS in the presence of microbeads. A) Count rates of one representative 
out of ten measurement intervalls of 15 s. B) Normalised autocorrelation curves calculated 
from ten measurements.  
The effect of nanoparticle-binding on parameters detected by FCS was 
characterised by a simple positive control. Lysine functionalised with biotin via its 
Nε-amino group and with 5(6)-carboxyfluorescein via its Nα-amino group (Fluo-K-
Bio) was subjected to FCS measurement either alone or in the presence of 
streptavidin-functionalised or proteinG-functionalised nanoparticles (Figure 27). 
Compared to a bead-free solution of Fluo-K-Bio, the addition of beads functionalised 
with protein G to Fluo-K-Bio led to a slight decrease in the count rate (Figure 27 A) 
while the autocorrelation curve was not shifted (Figure 27 B). In contrast, addition of 
beads functionalised with streptavidin led to a strong decrease in the count rate at 
most timepoints with frequent high peaks during the measurement intervall (Figure 
27 A). The autocorrelation curve of Bio-K-Fluo in the presence of streptavidin-beads 
was shifted strongly towards longer correlation times (Figure 27 B). 
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Figure 28: Identification of the constituents of protein complexes in cell lysate by mass-tag 
FCS. A - B) Interaction of ZAP-70-YFP with CD3ε.  Lysates were prepared from resting (-) 
or pervanadate-treated (+PV) cells. pITAM (pI) was used at a concentration of 2 µM. Lysates 
were incubated with anti-CD3ε antibody (ε) or a non specific isotype (iso) and protein G 
beads. A) Normalised average autocorrelation curves from ten repeated measurements of one 
representative experiment. Western blotting for ZAP-70 in the identical samples. B) 
Influence of the addition of primary antibodies with and without mass-tag on the relative 
diffusion time of ZAP-70-YFP-containing particles. Means and standard deviations of ten 
repeated measurements of one representative experiment are shown. C-D) Mass tag-mediated 
detection of the interaction of endogenous ZAP-70 and CD3ε. Biotinylated hamster anti-
CD3ε antibody, streptavidin-beads, mouse anti-ZAP-70 antibody (Z) and anti-mouse Fab-
Alexa647 were added in one step. For negative controls, a non specific mouse isotype 
antibody (iso) was used. C) Average autocorrelation curves and D) diffusion times τD as 
means and standard deviations from 10 repeated measurements of one representative 
experiment. 
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In the first experiments, detection was based on the intrinsic fluorescence of 
ZAP70-YFP (Figure 25 A, Figure 28 A, B). Incubation with anti-CD3ε antibody and 
protein G-beads led to a pronounced right-shift of the autocorrelation function in 
lysates of pervanadate-treated cells, resulting in a significantly (p<10-3) increased 
diffusion autocorrelation time τD. Autocorrelation curves from samples containing 
an isotype antibody instead of anti-CD3ε followed the changes described for ZAP70-
YFP (Figure 24 A). Addition of the inhibitory pITAM peptide completely reversed 
the stimulation dependent increase of τD. Alle FCS measurements were carried out in 
20 µl sample volume. 130 µl of the same samples were subjected to 
immunoprecipitation of CD3ε and western blotting for ZAP-70, confirming their 
pervanadate-induced interaction and a residual interaction after pITAM addition. 
We next extended the detection by mass-tags to complexes of endogenous 
proteins (Figure 25 B, Figure 28 C,D). Biotinylated anti-CD3ε-antibody, streptavidin-
conjugated microbeads, anti-ZAP70 antibody and cognate secondary Fab-fragment 
labelled with Alexa-647 were added to lysates of 3A9 cells. In lysates of pervanadate-
treated cells, τD of the fluorescent probe was reduced, indicating interaction of 
ZAP70 with CD3ε. In control samples, an isotype antibody was used instead of anti-
ZAP70, and no changes of τD were observed upon pervanadate-treatment.  
The pervanadate-dependent increase of the diffusion time τD was reproducibly 
detected for the interaction of endogenous ZAP70 and CD3ε. This showed in a 
proof-of-principle fashion, that FCS and indirect immunolabelling with one 
fluorophore and one mass tag can be employed to detect signalling-dependent 
interactions of endogenous proteins from a few microliters of crude cell lysate.  
 However, the standard deviations of the repeated measurements were always 
very high (Figure 28 D). This was likely caused by stochastic occurrence of 
differently sized fluorescent complexes of nanobeads, primary antibodies, target 
proteins and fluorophore-labelled F(ab) fragments. While the method would still 
allow binary decisions on whether or not an investigated protein-protein interaction 
takes place, it would not allow detection of gradual differences. We therefore 
searched for alternatives for mass-tag-labelling in the correlation spectroscopy based 
detection of protein-protein interactions.  
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5.2.2.2 Fluorescence Cross Correlation Spectroscopy 
We opted for fluorescence cross correlation spectroscopy (FCCS; Figure 21 B). 
Again, for first experiments the 3A9 cells expressing ZAP70-YFP at a level 2.5-fold 
over that of endogenous ZAP70 (149) were used (Figure 25 A). Cells were activated by 
incubation with the phosphatase inhibitor sodium pervanadate (142). Lysates were 
prepared of pervanadate-treated cells and untreated control cells. The YFP moiety of 
ZAP70-YFP served as one fluorescent probe for FCCS. The presence of CD3ε or ζ in a 
complex with ZAP70-YFP was probed using cognate monoclonal antibodies and 
Cy5-labelled secondary antibodies.  
In FCCS, the amplitude of the cross-correlation function is a measure of the 
fraction of particles carrying both fluorophores (Figure 4). For CD3ε, a pronounced 
cross-correlation between YFP and Cy5 was observed in lysates of pervanadate-
treated cells. In lysates of resting cells and of pervanadate-treated cells lacking the 
anti-CD3ε antibody, no cross-correlations were observed. Analogous changes were 
observed for the interaction of ZAP70-YFP with CD3ζ. The cross-correlation 
amplitudes were considerably lower than in the experiments probing for the 
interaction with CD3ε, likely due to different affinities of the antibodies for their 
respective targets (Figure 29 A). For changes upon pervanadate treatment, p-values 
of Student’s t-test were p < 10-7 for detection of the interaction with CD3ε and p < 10-6 
for the detection of the interaction with CD3ζ. Control samples were prepared 
without addition of primary antibody against CD3ε or CD3ζ. All control samples 
displayed only minimal crosscorrelation amplitudes, irrespective of pervanadate 
treatment. Student’s t-test for comparison of samples with and without primary 
antibody revealed 10-2 < p < 0.5 for lysates from resting cells, and 10-10 < p < 10-5 for 
lysates from PV-treated cells (not shown). The results were highly reproducible for 
independent experiments. Addition of the inhibitory pITAM peptide significantly 
decreased the cross-correlation amplitude of ZAP70-YFP and indirectly 
immunolabelled CD3 ε or ζ relative to the value determined in lysates of stimulated 
cells without addition of peptide.  
Addition of an unphosphorylated control peptide was without effect. Both 
peptides were used at a concentration of 1 µM (Figure 29 A).The inhibitory action of 
the pITAM peptide was further utilised for titration of complexes with increasing 
concentrations of peptide. pITAM was present in final concentrations between 0.1 
µM and 5 µM in the lysate of PV-treated cells. With increasing pITAM concentration, 
the cross-correlation amplitude decreased, revealing an IC50 of 1 µM pITAM-peptide 
for the interaction of ZAP-70-YFP and CD3ε (Figure 29 B). 
FCS and FCCS for the detection of signalling complexes 
 77
 
Figure 29: Identification of the constituents of protein complexes in cell lysates using FCCS. 
Lysates were prepared from resting (-PV) or pervanadate-treated (+PV) cells. Optionally, 
ITAM- (I) or pITAM-peptide (pI) was added. A) Cross-correlation amplitudes for the 
interaction of ZAP-70-YFP with CD3ε or CD3ζ, labelled by addition of anti-CD3ε or -ζ 
primary and Cy5-conjugated secondary antibodies (black columns). In controls, primary 
antibodies were omitted (white columns). Means and standard deviations for one 
representative experiment are shown. Numbers x above columns designate p-values for 
comparison of samples containing primary antibody (10-(x+1) < p < 10-x). B) Cross-correlation 
curves for the titration of ZAP-70-YFP-CD3ε complexes with pITAM. Average curves from 
10 repeated measurements of one representative experiment are shown. C) Interaction of 
endogenous ZAP-70 and CD3ε, detected by fluorescence cross-correlation of an Alexa488-
labelled anti-mouse antibody and streptavidin-Cy5. Primary antibodies were anti-ZAP-70 
from mouse (Z) and biotinylated anti-CD3ε from hamster (ε). In controls, either one or both 
of the primary antibodies were omitted. Average curves from 10 repeated measurements of 
one representative experiment are shown. Numbers x next to the curves indicate p-values 
(10-(x+1) < p < 10-x) for the comparison of samples containing both antibodies. D) 
Reproducibility of results from 3 independent experiments as decribed in C). Data sets were 
internally normalised to the cross-correlation amplitude of the pervanadate-treated sample 
containing both primary antibodies. Mean values and error propagations of the standard 
deviations of the single experiments are shown. 
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To extend the analysis of molecular complexes by FCCS to complexes 
containing only unlabelled endogenous proteins, we next employed lysates of 
untransfected 3A9 cells (Figure 25 B). Lysates were prepared at 5*107 cells/ml. Mouse 
anti-ZAP70 and hamster anti-CD3ε primary antibodies and matching secondary 
reagents labelled with distinct fluorophores were directly added to the lysates. 
(Figure 29 C). As controls, one or both of the primary antibodies were omitted. For 
the controls containing only one primary antibody, cross-correlations with low 
amplitudes were detectable independent of pervanadate treatment. These signals 
were likely due to a slight cross-reactivity of the Alexa488-labelled anti-mouse 
antibody with the hamster antibody or to an unspecific interaction of Cy5-
streptavidin with complexes containing anti-mouse antibodies. In samples 
containing both primary antibodies, the cross-correlation amplitude for 
pervanadate-treated cells was significantly higher than the one in resting cells (p < 
10-3; Figure 29 C). In a sample containing pITAM peptide at a concentration of 2 µM, 
the pervanadate-dependent increase of the cross-correlation amplitude was partially 
reverted. The background of cross-correlations of low amplitudes was consistently 
found in repeated experiments (Figure 29 D).  
In a corresponding manner, we probed additional signalling-dependent 
interactions of endogenous proteins in lysates of resting and stimulated 3A9 cells. 
Additionally, human Jurkat T leukemia cells were included as a second cell line. In 
3A9 cells, the SH2-mediated interactions of GRB2 or PLCγ1 with LAT were detected 
after pervanadate treatment. By contrast, the GRB2-LAT interaction was not 
detectable in Jurkat lysates, while the PLCγ1-LAT interaction was detected with 
similar cross-correlation amplitude compared to the one in 3A9 lysates. 
Additionally, the SH3-mediated interaction of PLCγ1 with SLP76 was detected in 
Jurkat lysates in a stimulation-dependent manner (Figure 30). For all pairs of 
primary and cognate labelled secondary antibodies used in the FCCS-measurements, 
the autocorrelation functions of the fluorescent labels revealed the presence of 
slowly diffusing particles, likely corresponding to crosslinked primary and 
secondary antibodies (not shown).  
However, the propensity for formation of crosslinked aggregates varied, 
depending on the primary antibody used. The mouse IgG2a anti-SLP76 antibody 
turned out to be especially prone to aggregate with the labelled anti-mouse IgG 
antibody, resulting in large standard deviations for the detection of the pervanadate-
dependent SLP76-PLCγ1 interaction (Figure 30). In this case, the bivalent labelled 
anti-mouseIgG was replaced with monovalent labelled anti-mouse IgG2a F(ab) 
fragments, resulting in smaller standard deviations (chapter 4.1.3, Table 7, p. 35). 
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Figure 30: Further stimulation-dependent interactions of endogenous proteins detected by 
indirect immunolabelling and FCCS. Lysates of resting or pervanadate-treated Jurkat or 3A9 
cells. Per sample, 106 cells/20µl lysate were used. Pairs of primary antibodies, one each from 
mouse and rabbit and species-specific secondary antibodies labelled with Alexa488 or 
Alexa633 were added in one step. Control samples contained lysis buffer instead of cell lysate. 
Data from 3 (LAT-GRB2 in Jurkat: 2) independent experiments is presented as mean values 
with eror bars corresponding to the error propagations of the standard deviations of the single 
experiments. 
 
5.2.2.3 Dissection of the LAT-signalosome with interacting peptides 
At this point, the FCCS-based detection of protein complexes had proven to be 
a facile approach for the detection of protein-protein interactions from microlitre 
volumes of lysates, which could easily be adapted to several interactions. Due to the 
on-step setup of the samples, the method would lend itself to screening applications, 
for example in the screening of substances interfering with protein complex 
formation. For the identification of effective substances for protein complex disrup-
tion, the ability to quantitatively compare their activities is mandatory. We therefore 
intended to further test the FCCS-based protocol for the detection of gradual 
differences in protein-protein interactions and the determination of IC50 values for 
inhibitors of interactions (The IC50 value is the concentration of an inhibitor, at which 
the signal – in our case the cross-correlation amplitude – observed for the 
uninhibited system is reduced to 50%). 
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Figure 31: Cross correlation amplitudes for the titration of interactions in the LAT-
signalosome with interfering peptides. Lysates of resting (rest.) or pervanadate-treated (PV) 
Jurkat cells at 106 cells/20µl. Dotted lines represent mean cross-correlation amplitudes in 
samples without peptide addition. Mean values and standard deviations of 10 repeated 
measurements in one representative experiment A) Titration of LAT-PLCγ1 interaction in 
lysates of pervanadate-treated cells with peptides LATpY132 and LATpY191 and the 
unphosphorylated control peptide LAT-Y191. The raw data for this experiment is partially 
shown in Table 5 (p. 34). B) Titration of SLP76-PLCγ1 interaction in lysates of 
pervanadate-treated Jurkat cells with peptides LATpY132, SLP228 and SLP179. C) Titration 
of SLP76-GADS interaction in lysates of resting and pervanadate-treated Jurkat cells with 
peptide SLP228. D) Schematic of the signalling complex of LAT, SLP-76, PLCγ1, and 
GADS. The SH2 domain binding binding sites on LAT are mimicked by LATpY132 and 
LATpY191. The SH3 domain binding sites on SLP76 are mimicked by SLP179 and SLP228. 
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We picked the interactions of LAT, GADS, SLP76 and PLCγ1 in the LAT-
signalosome. As competitors, we chose peptides corresponding to binding motifs of 
one partner in the protein complexes (Figure 31), which had also been employed on 
the peptide microarrays (chapter 5.1.3). The phosphotyrosine (pY) motifs of LAT 
provide docking sites for the SH2 domains of GADS and PLCγ1 (42). Some level of 
redundancy of the individual pY residues for binding different signalling proteins 
has been reported. pY132 was identified as the principal PLCγ1-binding site by in 
vitro peptide competition experiments (131). In vivo point mutations on LAT have 
defined an additional requirement for pY191 for PLCγ1 binding (47). On the other 
hand, pY191 was reported to be the preferred binding site for the SH2 domain of 
GADS (46). Our own experiments on peptide microarrays including LATpY132 and 
LATpY191 are in line with these findings (Figure 14 C, p. 51). 
The SH2-dependent interaction of LAT and PLCγ1 was disrupted by titration 
with pY-motif peptides, but not disrupted even by high concentrations of polyP 
motif peptides (Table 10). The LATpY132 peptide corresponding to the supposed 
binding site acted more efficiently than the LATpY191 peptide. IC50 values of 
approximately 0.5 µM for LATpY132 and 20 µM for LATpY191 were determined. An 
unphosphorylated control peptide corresponding to LATY191 had no effect on the 
cross-correlation amplitude even at high concentrations (Figure 31 A, Table 10). In a 
previous publication using peptide concentrations of up to 10 µM and 
immunoprecipitation in combination with western blot for detection, no effect of the 
pY191 peptide on the LAT-PLCγ1 interaction had been detected (131). The relative 
activities of both peptides as we observed them are consistent with a direct binding 
of PLCγ1 to pY132 and an auxiliary function of pY191. pY191 has also been 
implicated in binding of the adapter protein GADS, and therefore instead of directly 
binding to PLCγ1 may contribute to stabilising the tetrameric core signalosome of 
LAT, GADS, SLP76 and PLCγ1 (131,47,132) (Figure 31).  
The interaction of SLP76 and PLCγ1 was only detected after pervanadate 
treatment and was sensitive to titration with polyP peptide SLP179 (IC50 = 25 µM), 
the supposed direct competitor for the interaction (49). The polyp peptide SLP228 
(supposed to compete for the GADS-SH3 binding to SLP76) disrupted the SLP76-
PLCγ1 interaction with an IC50 of 10 µM. In the peptide microarray experiments 
using these peptides, we detected PLCγ1 from resting cells on SLP179, but not on 
SLP228. Only after pervanadate-treatment, PLCγ1 was found on SLP228 (Figure 14 
C) and could be detached from this spot by titration with LATpY132 and LATpY191 
(Figure 17 C, p. 57). This suggests that the inhibitory action of SLP228 seen in the 
FCCS-experiment probing the SLP76-PLCγ1 interaction was caused by destabilising 
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the LAT-signalosome between SLP76 and GADS – and subsequent dissociation of 
SLP76 – rather than by direct interference at the SLP76-PLCγ1 binding site.  
Moreover, the pY motif peptide LATpY132 disrupted the SLP76-PLCg1 
interaction with an IC50 of 0.5 µM, exactly as found for the LAT-PLCγ1 interaction. 
This strongly suggests, (i) that the mode of action for LATpY132 on this SH3-
mediated interaction is indirect and (ii) that the SLP76-PLCγ1 interaction plays 
merely a stabilising role in the LAT-signalosome and is not sufficient to hold PLCγ1 
in place. 
By contrast, the SH3-mediated interaction between SLP76 and GADS is 
constitutive, and was already detected in lysates of resting cells. It could be 
disrupted by SLP228 with an IC50 of 5 µM. pY peptides had no effect on the SLP-
GADS interaction in resting cells. Upon activation of cells with pervanadate, cross-
correlation amplitudes for the SLP-GADS interaction decreased relative to the 
resting state, but could still be further suppressed by titration with SLP228. The 
decreased cross-correlation amplitude may have been caused by poor accessibility of 
GADS for the antibody upon recruitment of GADS into larger complexes. 
Correspondingly, FCCS was not able to detect GADS in complex with LAT. 
 
 
 
 
Table 10: IC50 values for the titration of the interactions in the LAT-signalosome with 
interfering peptides. no effect: For up to 30 µM of the respective peptide, no systematic 
titration-dependent decrease of the cross-correlation amplitude was observed. DMF was 
employed at 1% (v/v) in the lysate, corresponding to the DMF concentration at 30 µM 
peptide. 
 LAT-PLCγ1 PLCγ1-SLP SLP-GADS GADS-LAT 
 stim. 
dependent 
stim. 
dependent 
constitutive not 
detectable 
LATpY132 IC50 0.5 µM IC50 0.5 µM no effect  n.d. 
SLP179 no effect  IC50 25 µM no effect  n.d. 
SLP228 no effect  IC50 10 µM IC50 5 µM n.d. 
LATpY191 IC50 20 µM n.d.  no effect  n.d. 
DMF 
control 
no effect  no effect  no effect  n.d. 
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5.2.2.4 Discussion 
FCCS and FCS were employed for detecting interactions of endogenous 
signalling proteins after indirect immunolabelling in microliter volumes of crude cell 
lysates. To our knowledge, this is the first report of the FCS-based detection of 
molecular complexes by indirect immunolabelling of both components. In the vast 
majority of previous reports applying FCS or FCCS, the binding partners were either 
expressed as fluorescent fusion proteins or chemically labelled, thereby requiring 
dedicated experimental designs and limiting the application of these techniques to 
the detection of selected molecular interactions.  
Especially for the screening of substances that interfere with complex 
formation, crude cell lysates containing endogenous proteins only are highly 
preferable over reconstituted systems. First, posttranslational modifications are 
formed in the physiological context. Second, the formation of some complexes may 
depend on further proteins in an activation-dependent manner (162). The screening of 
inhibitors that interfere with such interactions would therefore require the in vitro 
reconstitution of highly complex signalling machineries. In our case, inhibitors of 
interactions that depend on the phosphorylation of tyrosine residues were compared 
for their ability to interfere with the interactions constituting the LAT-signalosome in 
T-cell signalling. 
In comparison to co-immunoprecipitation and western blotting, one of the 
assets of our approach also defines its limitations: The enrichment and purification 
of complexes is an intrinsic characteristic of co-immunoprecipitation. The FCCS-
based method omits enrichment and washing steps by employing antibodies under 
equilibrium binding conditions directly in crude cell lysates. Furthermore, in 
western blotting, the determination of relative molecular weights provides 
additional information on the specificity of the reagents and the presence of protein 
isoforms. As this intrinsic control is missing in FCCS, it is advisable to use well-
characterised antibodies known to be specific for their target. 
There may be situations in which the detection of complexes is not possible by 
FCCS. Complexes of low abundance proteins may escape detection, because they 
cannot be sufficiently enriched. Rare complexes of high abundance proteins may 
escape detection, because uncomplexed proteins bind a major part of the antibodies. 
On the other hand, rare complexes of high abundance proteins may also be prone to 
dissociation when the unbound fraction is removed from equilibrium by washing 
steps in conventional enrichment techniques. Working under equilibrium conditions 
using FCCS may therefore still be beneficial in these cases. Similar limitations apply 
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if one of the two partners in a protein complex is significantly more abundant than 
the other.  
As our approach for labelling and FCS respectively FCCS detection is 
conceptually very straightforward, it may seem surprising that it has not been 
described before. Indirect immunolabelling may have been shunned in FCS and 
FCCS based on two assumptions.  
First, cross-linking of primary antibodies and multivalent secondary reagents 
(like whole antibodies or streptavidin) may lead to the formation of large fluorescent 
aggregates which compromise the evaluation of autocorrelation functions. In our 
FCCS experiments, some antibody aggregation was obvious from the contribution of 
slowly diffusing components to the autocorrelation function of the fluorescent label 
of the secondary antibody. However, this contribution did not interfere with the 
detection of complex formation, as the cross-correlation amplitude was only 
dependent on the inducible interaction of the examined proteins. Moreover, for 
primary antibodies especially prone to aggregate with whole bivalent secondary 
IgG-antibodies, monovalent secondary F(ab) fragements could be used. One should 
note that in contrast to the FCCS measurements, in the mass-tag strategy large 
aggregates of analytes and beads are generated intentionally as a readout. Therefore, 
all reagents that may cause aggregates by themselves must be avoided in 
combination with mass-tags. Consequently, we used fluorescently labelled 
monovalent F(ab)-fragments instead of bivalent secondary antibodies.  
Second, the detection of a protein complex by indirect immunolabelling 
depends on the presence of five molecular interactions (Figure 25, p. 71), each with 
its own binding equilibrium. One should therefore assume that only a minor fraction 
of the protein complexes is simultaneously labelled with both fluorescent reagents. 
The calculation of fractions of bound versus unbound molecules in antibody-antigen 
complexes allows an estimation of the range of dissociation constants Kd and binding 
partner concentrations allowing FCCS detection:  
The dissociation constant Kd can be written as: 
 [ ] [ ][ ]
[ ] [ ]( ) [ ] [ ]( )
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AgAbAbAgAbAg
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AbAgK tottotd
−⋅−=⋅=
 
Eq. 18 
 
with [Ag], [Ab], [AgAb] designating the equilibrium concentrations of free 
antigen, free antibody and antigen-antibody complex, and [Agtot], [Abtot] designating 
the total concentration of both binding partners. Eq. 18 can be resolved for [AgAb], 
resulting in a quadratic equation with Kd, [Agtot] and [Abtot] as parameters. The 
requirement to use approximately 10 nM (1.5 µg/ml assuming an IgG with a MW of 
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150kD) of labelled secondary reagent for FCCS-detection imposes constraints on the 
optimisation of the relative concentrations of binding partners.  
With respect to protein complex detection by FCCS as described above, [Abtot] = 
10nM is the concentration of an antibody in the sample, and both its Kd for binding 
its target and the concentration of the target in the lysate are unknown. Table 11 lists 
various combinations of Kd and [Agtot] in the range that can be expected for the 
experimental setup described above, and resulting concentrations of [AgAb], and 
fractions of bound antibody and bound antigen. A number of conclusions can be 
drawn within the framework given by Table 11: 
(i) For detection of protein interaction by indirect immunolabelling and FCCS, 
an excess of unlabelled antigen is as deleterious as an excess of unbound antibody. 
With any given dissociation constant, the most advantageous situation will arise if 
antigen and antibody are equimolar. The same line of reasoning applies to the 
relative concentrations of primary and secondary antibodies. Antibody 
concentrations of 10 nM are routinely used; therefore the ideal target protein 
concentration is likewise 10 nM. With typical lysate concentrations of 5*107 cells/ml 
lysis buffer, this corresponds to 120,000 copies of the target protein per cell. This is 
well in the range of our own analysis for ZAP70 (confer p. 40) and published data for 
various proteins from the MAP kinase cascade (163).  
(ii) As a consequence the only parameter that can be changed considerably in 
order to optimise the fraction of doubly labelled particles, is the concentration of the 
cell lysate. As Table 11 suggests, we observed that decreasing the concentration of 
the target proteins by preparing lysates of lower cell density in some cases was 
crucial to reach a higher fraction of doubly labelled complexes (shown in (145)).  
(iii) The dissociation constants of the antibodies determine the fractions of 
labelled, and therefore detectable, proteins. Unfortunately, most commercial 
antibodies are not characterised with respect to their dissociation constants. 
However, the ideal working concentration for FCCS of 10 nM (1.5 µg/ml) is in the 
range generally used for many other antibody-based techniques, indicating that 
dissociation constants of antibodies are usually low enough to yield results at these 
concentrations. Even if all five dissociation constants involved in giving rise to the 
doubly labelled species monitored (Figure 25) are in the range between 10-8M and 10-
9M, doubly labelled fractions on the order of a few percent can be expected. Indeed, 
we have found that indirect immunolabelling as described in this protocol affords 
fractions of doubly labelled particles on the order of a few percent of total labels in 
the samples. These are sufficient for a reliable detection by FCCS.  
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Table 11: Model calculation for bound fractions of molecules in an antibody (Ab) – antigen 
(Ag) interaction, depending on total concentrations of binding partners [Agtot], [Abtot] and 
the dissociation constant Kd of the interaction.The last column “fraction5” lists the likelihood, 
that 5 interactions with the given parameters coincide, as is the case for FCCS-detection by 
indirect immunolabelling. Bold type distinguishes situations where [Agtot] = [Abtot], which 
are advantageous with respect to detection by FCS or FCCS. 
Kd / M [Agtot] / 
M 
[Abtot] / 
M 
[AgAb] 
/M 
[AgAb]/ 
[Agtot] 
= fraction of  
bound Ag 
[AgAb]/ 
[Abtot] 
= fraction of 
bound Ab 
fraction 5 
 1.00E-07 1.00E-08 9.01E-09 0.09 0.90  
1.00E-08 1.00E-08 1.00E-08 3.82E-09 0.38 0.38 0.008 
 1.00E-09 1.00E-08 4.88E-10 0.49 0.05  
 1.00E-07 1.00E-08 9.89E-09 0.10 0.99  
1.00E-09 1.00E-08 1.00E-08 7.30E-09 0.73 0.73 0.207 
 1.00E-09 1.00E-08 9.01E-10 0.90 0.09  
 1.00E-07 1.00E-08 9.99E-09 0.10 1.00  
1.00E-10 1.00E-08 1.00E-08 9.05E-09 0.90 0.90 0.590 
 1.00E-09 1.00E-08 9.89E-10 0.99 0.10  
 1.00E-07 1.00E-08 1.00E-08 0.10 1.00  
1.00E-11 1.00E-08 1.00E-08 9.69E-09 0.97 0.97 0.859 
 1.00E-09 1.00E-08 9.99E-10 1.00 0.10  
 
 
Contrary to what may be expected from the potential limitations listed above, 
little optimisation was required in the cases for which we have measured cross-
correlations. All antibodies that we successfully used were from commercial sources 
with no prior selection for exceptionally high affinity. In general, primary antibodies 
validated for immunoprecipitation also performed well in the FCS and FCCS 
experiments. 
The simplicity of our protocol and the general availability of reagents 
significantly extends the applicability of FCS and FCCS in the detection of protein 
complexes. With growing collections of highly specific antibodies the method is 
applicable to a basically unlimited array of interactions. Table 12 tentatively 
compares FCCS-based detection of interactions with existent approaches for large-
scale interaction screens. In comparison to other approaches for the scanning of 
protein-protein interactions, FCCS as presented here is notable for its potential to 
pick up the interaction of endogenous, untagged proteins from microlitre amounts 
FCS and FCCS for the detection of signalling complexes 
 87
of sample in a simple “mix, incubate, and measure” protocol. FCCS-based scanning 
for protein-protein interactions relies on a library of antibodies. In contrast, 
established methods may require the construction of extensive libraries of fusion-
proteins. Due to the confocal detection volume and the nanomolar sensitivity of 
FCCS, minimal amounts of sample and reagents are needed. Moreover, the 
straightforward protocol avoids sample loss during prolonged handling and allows 
for easy automation. 
 
 
 
 
Table 12: Comparison of the FCCS-based technique to other techniques employed for 
scanning of protein-protein interactions  
 2-Hybrid Tandem Affinity 
Purification + Mass 
Spectrometry (164) 
Whole Interactome 
Scanning 
Experiment (11) 
FCCS  
or  
mass-tag FCS 
Physical basis 
for screening 
libraries of bait & prey 
fusion proteins 
library of tandem-
tagged proteins 
arrayed library of 
peptides 
library of 
antibodies 
Whose 
interaction is 
detected? 
2 overexpressed 
exogenous proteins 
tagged exogenous 
protein with 
endogenous proteins 
endogenous protein 
with arrayed 
peptides 
unmodified 
endogenous 
proteins  
Interaction 
detected 
where? 
in living cells from lysate, after 
purification 
from lysate, after 
washing the array 
in crude lysate at 
equilibrium 
Additional 
features 
usually pairwise 
constitutive inter-
actions; modifications 
for detection of con-
stitutive interactions 
(165) 
unbiased detection 
mode, no selection of 
affinity reagents for 
detection necessary 
 pairwise 
constitutive and 
inducible 
interactions 
mix and measure:
one-step protocol 
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6 Summary 
The aim of this thesis was to develop methods for the parallel analysis of com-
plexes of endogenous proteins, and to employ them in the context of T-cell signal 
transduction. As a general rule, all efforts to monitor a system lead to the 
introduction of changes into this system. The dissection of protein-protein inter-
actions in cellular signalling requires the introduction of detectable features to 
distinguish proteins from one another. Two basic options exist: Either a label (in the 
broadest sense) is introduced into the intact cells – this allows to follow signalling 
processes in a live, but manipulated cellular system. Alternatively, signalling is 
induced in unmanipulated cells, which are then disrupted – this allows to introduce 
labels after the signalling processes of interest have taken place in their unperturbed 
physiological context. We opted for the second possibility, as the labelling of 
proteins in lysates is more versatile and therefore more amenable to parallelisation 
compared to the labelling of proteins in life cells. Two approaches were developed, 
one based on peptide microarrays, the other one on fluorescence correlation and 
cross correlation spectroscopy. 
We show that peptide microarrays provide a robust and quantitative means for 
detecting signalling-dependent changes of molecular interactions. Recruitment of a 
protein into a complex upon stimulation of a cell leads to the masking of an 
otherwise exposed binding site. In cell lysates this masking can be detected by 
reduced binding to a microarray carrying a peptide that corresponds to the binding 
motif of the respective interaction domain. Compared to established techniques, the 
method provides a significant shortcut to the detection of molecular interactions. 
This approach was first exemplified for the binding of ZAP70 to a bis-pY-motif of 
the activated T-cell receptor via its tandem SH2 domain. Binding of ZAP70 to the 
microarray was either detected by virtue of the intrinsic fluorescence of a ZAP70-
YFP fusion protein or by indirect immunofluorescence. In both cases, the activation-
dependent recruitment of ZAP70 into signalling complexes reduced the microarray-
bound signal. This reduction in signal provided quantitative information on the 
change of the fraction of available binding sites and, through combination with FCS 
and western blotting, even on the number of available and occupied ZAP70 tandem-
SH2 domains per cell. 
We then extended the concept by using arrays comprising 15 SH2 domain-
binding pY motif peptides, 6 SH3 domain-binding polyP motif peptides, 1 PTB-
binding peptide, 1 WH1-binding peptide and 1 PDZ-binding peptide. Lysates of 
resting or stimulated Jurkat cells were incubated on these arrays and the binding of 
two signalling proteins per array was detected by two-colour indirect 
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immunofluorescence. With 16 arrays per slide incubated in parallel, this approach 
yields 768 data points on protein-protein interactions in cellular signalling per 
experiment, or multiples of this number if several slides are incubated in parallel. In 
addition to changes caused by the masking of binding sites, we found that also 
recruitment of proteins into complexes leads to signal changes. This endows the 
arrays with properties of co-purification methods, but in a highly parallel and 
miniaturised fashion. Competition with peptides corresponding to interaction motifs 
dismantled complexes on the arrays in a stepwise and dose dependent manner and  
provided detailed information on the architecture of signalling complexes. For 
stimulation of Jurkat cells through receptor crosslinking with anti-CD3 and/or anti-
CD28 antibodies, the timecourse of the changes in the pattern of molecular 
interactions could be monitored. Experiments with Jurkat cell derivatives lacking 
either an upstream signalling kinase or a protein involved in a central signalling 
complex demonstrate that the peptide arrays provide a means to dissect functional 
interdependences in cellular signalling networks.  
FCCS and FCS were used to detect interactions of endogenous signalling 
proteins using simple “mix, incubate, and measure” protocols in microliter volumes 
of crude cell lysates. Both binding partners of interest were targeted by indirect 
immunolabelling. Using 384-well plates, measurements were conducted in as little 
as 20 µl crude cell lysate per sample, corresponding to 0.2 - 1 * 106 cells. Matched 
pairs of primary antibodies against the interaction partners and labelled secondary 
reagents were all added to the crude cell lysates in one step. The indirect labelling of 
two constituents of a complex enabled the specific and sensitive detection of 
signalling-dependent complex formation. FCCS, using two spectrally different 
fluorophores as labels, proved superior to FCS, using one fluorophore and one mass-
tag. The one-step addition of reagents and separation-free detection minimise the 
number of manipulations required for complex detection and make the protocol 
readily compatible with automation. So far, we have applied the method for 
detecting the signalling-dependent formation of molecular complexes in T-cell signal 
transduction. Moreover, we demonstrate that IC50 values for substances interfering 
with protein-protein interactions can be determined. Competition experiments with 
peptides disrupting interactions constituting a central protein complex in T-cell 
signalling, the LAT-signalosome, revealed the relative importance of the individual 
interactions in stabilising the complex.  
We therefore conclude, that the FCCS-based approach on protein complex 
detection is well suited for the parallel detection of a set of protein-protein 
interactions within a cellular signalling network, in applications relating to systems 
biology. Data sets on the evolution of interactions over time in response to different 
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stimuli may be generated with comparably little effort. Here, the ability to work with 
systems containing only endogenous proteins is especially advantageous, as 
overexpression of fusion-proteins with detection tags may favor the formation of 
protein complexes and distort signalling pathways. Another application might be 
the screening for inhibitory substances of protein-protein interactions. Inhibitors can 
be ranked by determining their IC50 values through titration. Especially for 
interactions depending on signalling-dependent posttranslational modifications, an 
approach based on endogenous proteins in their native cellular context is preferable 
over reconstituted systems. With a growing body of experience, one may envision 
future applications in the screening for new interactions and the generation of 
interaction maps using libraries of antibodies. 
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7 Zusammenfassung 
Ziel dieser Doktorarbeit war, im Kontext der T-Zell-Signaltransduktion 
Methoden zur parallelen Analyse von Komplexen endogener Proteine zu 
entwickeln. Generell gilt, dass jeder Versuch, ein System zu beobachten, bereits 
Veränderungen in diesem System hervorruft. Die Aufklärung von Protein-Protein-
Interaktionen im zellulären Signalgeschehen verlangt die Einführung von detektier-
baren Merkmalen, um Proteine voneinander zu unterscheiden. Dafür gibt es zwei 
grundlegende Möglichkeiten: Entweder wird eine Markierung (im weitesten Sinne) 
in die intakten Zellen eingebracht – dies erlaubt das Verfolgen von Signalvorgängen 
in einem lebenden, jedoch bereits veränderten System. Alternativ wird das 
Signalgeschehen in unveränderten Zellen induziert, die dann lysiert werden – dies 
erlaubt die Einführung von Markierungen, nachdem die zu untersuchenden Signal-
vorgänge in ihrem unveränderten physiologischen Kontext abgelaufen sind. Wir 
entschieden uns für die zweite Möglichkeit, da die Markierung von Proteinen in 
Lysaten flexibler einsetzbar und daher einfacher parallelisierbar ist als die Markie-
rung von Proteinen in lebenden Zellen. Zwei Herangehensweisen wurden ent-
wickelt, die eine basierend auf Peptidmikroarrays, die andere basierend auf Fluores-
zenz-Korrelations- und Kreuzkorrelations-Spektroskopie (FCS / FCCS).  
Wir zeigen, dass Peptidmikroarrays einen einfachen Weg zur quantitativen 
Detektion signalabhängiger Protein-Protein-Interaktionen eröffnen. Die Einbe-
ziehung eines Proteins in einen Proteinkomplex führt zur Maskierung einer andern-
falls frei zugänglichen Bindungsstelle. In Zelllysaten lässt sich solch eine Maskierung 
detektieren, da sie auf einem Mikroarray, der ein zu der maskierten Bindungsstelle 
passendes Peptid-Bindemotiv trägt, zu verminderter Anbindung des Proteins führt. 
Im Vergleich zu bestehenden Techniken stellt diese Methode eine deutliche Verein-
fachung der Detektion molekularer Interaktionen dar. Dieser Ansatz wurde zu-
nächst beispielhaft validiert anhand der Bindung der Tandem-SH2-Domänen von 
ZAP70 an ein bis-pY-Motiv des aktivierten T-Zell-Rezeptors. Die Bindung von 
ZAP70 an ein entsprechendes Peptid auf dem Mikroarray wurde entweder durch 
die intrinsische Fluoreszenz eines ZAP70-YFP Fusionsproteins, oder durch indirekte 
Immunfluoreszenzfärbung detektiert. In beiden Fällen reduzierte die aktivierungs-
abhängige Einbeziehung von ZAP70 in Signalproteinkomplexe das Fluoreszenz-
signal auf dem Mikroarray. Diese Signalreduktion enthielt quantitative Information 
über die Änderung des Anteils verfügbarer Bindungsstellen und, kombiniert mit 
FCS und Western Blotting, über die Anzahl verfügbarer und maskierter ZAP70- 
Tandem-SH2-Domänen pro Zelle. 
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Anschließend wurde dieser Ansatz ausgeweitet, indem Mikroarrays mit 15 
verschiedenen SH2-Domänen-bindenden pY-Motiv-Peptiden, sechs SH3-Domänen-
bindenden polyP-Motiv-Peptiden, und je einem PTB-, WH1- und PDZ-Domänen-
bindenden Peptid zum Einsatz kamen. Lysate ruhender oder stimulierter Jurkat-
Zellen wurden auf diesen Arrays inkubiert und die Bindung von zwei Signaltrans-
duktionsproteinen per Array anschließend durch indirekte Immunfluoreszenz mit 
zwei verschiedenen Fluorophoren detektiert. Mit der parallelen Inkubation von 16 
Mikroarrays pro Objektträger liefert ein Experiment 768 Datenpunkte zu Protein-
Protein-Interaktionen in der zellulären Signaltransduktion - oder Vielfache dieser 
Zahl, wenn mehrere Objektträger parallel inkubiert werden. Zusätzlich zu den 
durch Maskierungseffekte hervorgerufenen Änderungen fanden wir, dass auch die 
Einbeziehung von Proteinen in Komplexe zu Signaländerungen führt. Dies verleiht 
den Mikroarrays Eigenschaften von Ko-Aufreinigungsmethoden, aber in hoch-
paralleler und miniaturisierter Art und Weise. Kompetitionen mit Peptiden, die den 
Bindemotiven innerhalb der Komplexe entsprachen, ermöglichten die schrittweise 
und konzentrationsabhängige Zerlegung der Komplexe auf den Arrays und lieferten 
somit detaillierte Informationen zur Komplexarchitektur. Nach Stimulation von 
Jurkat-Zellen durch Rezeptor-Kreuzvernetzung durch anti-CD3 und/oder anti-CD28 
Antikörper ließ sich der Zeitverlauf von Änderungen im Muster molekularer 
Interaktionen beobachten. Experimente mit Jurkat-Zellen, denen entweder eine 
aktive Kinase der frühen Signaltransduktion oder ein in viele Komplexe involviertes 
Protein fehlten, demonstrierten weiterhin, dass Peptidarrays funktionale 
Zusammenhänge in zellulären Signalnetzwerken zeigen. 
FCS und FCCS wurden genutzt, um Interaktionen endogener Signaltrans-
duktions-Proteine in einfachen „Misch, inkubier und miss“-Protokollen in Mikro-
litervolumina von Zelllysat zu detektieren. Beide hinsichtlich ihrer Bindung zu 
untersuchenden Proteine wurden indirekt immunmarkiert. Die Messungen wurden 
in Multititerplatten mit 384 Probenkammern in jeweils lediglich 20 µl Lysat pro 
Ansatz, entsprechend 0,2 – 1,0 * 106 Zellen, durchgeführt. Abgestimmte Paare von 
Primärantikörpern gegen die Bindungspartner und markierten Sekundärreagenzien 
wurden in einem Schritt zu den Zelllysaten gegeben. Diese indirekte Markierung 
zweier Komplexbestandteile ermöglichte die spezifische und sensitive Detektion von 
signalabhängiger Proteinkomplexbildung. FCCS unter Nutzung von zwei spektral 
unterschiedlichen Fluorophoren als Markierung erwies sich dabei als überlegen 
gegenüber der FCS mit einem Fluorophor und einem Nanopartikel als Massen-
markierung. Die Zugabe aller Reagenzien in einem Schritt und die von Trennungs-
schritten unabhängige Detektion minimieren die Zahl notwendiger Handhabungs-
schritte und machen die Methode kompatibel für die Automatisierung. Bisher haben 
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wir die Methode für die Detektion signalabhängiger Proteinkomplexe in der T-Zell-
Signaltransduktion eingesetzt. Daneben demonstrierten wir die Bestimmung von 
IC50-Werten für Inhibitoren der Komplexbildung. Titrationsexperimente mit 
Peptiden, die die individuellen Interaktionen in einem zentralen Komplex der T-
Zell-Signaltransduktion kompetieren, zeigten die relative Bedeutung der einzelnen 
Interaktionen für die Stabilisierung des gesamten Komplexes.  
Wir folgern daher, dass unser FCCS-basierter Ansatz zur Detektion von 
Proteinkomplexen gut geeignet ist, um mehrere Interaktionen innerhalb eines 
zellulären Signalnetzwerkes parallel zu verfolgen, beispielsweise in system-
biologischen Fragestellungen. Datensätze zur Entwicklung von Interaktionen über 
die Zeit und in Antwort auf unterschiedliche Stimuli könnten so mit vergleichsweise 
wenig Aufwand generiert werden. In diesem Zusammenhang ist es besonders 
vorteilhaft, in Systemen mit ausschließlich endogenen Proteinen arbeiten zu können, 
da die Überexpression von Fusionsproteinen mit Detektionsmarkierungen die 
Bildung von Proteinkomplexen favorisieren und das zelluläre Signalgeschehen 
verzerren könnte. Eine weitere Anwendung kann die Reihenuntersuchung 
potentieller Inhibitoren von Protein-Protein-Interaktionen sein. Inhibitorkandidaten 
ließen sich dabei anhand ihres durch Titrationen ermittelten IC50-Wertes ver-
gleichend beurteilen. Vor allem für Interaktionen, die auf posttranslationalen 
Modifikationen beruhen, ist ein auf endogenen Proteinen in ihrem natürlichen 
zellulären Kontext basierender Ansatz einem rekonstitutierten System vorzuziehen. 
Mit wachsender Erfahrung mit der Methode ist auch vorstellbar, sie zukünftig für 
die Neuidentifikation von Interaktionen mit Hilfe von Antikörper-Bibliotheken 
einzusetzen.  
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